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>Smt/iARY
KPIDKMIOLOGIGAL AMD UORMONS STUDIED IM EARLY H U m N  
PREGNANCY - NORMAL AND ABNORMAL
By> MeC# Mappaughtoïî M.E* Ch*B*(Glas») F*r ,c «o *0*
€ In apt or I* Introduction to tRo Thesis #
Chapter 2* Epidemiological studieo in abortion* and 
subsequent reproductive performance.
K  Nomen who start childbearing with Î or 2 consecutive 
abortions are compared with those who start with 
1 or 2 normal pregnancies♦
2. Women who start childbearing with 2 abortions aro 
olderp shorter and of lowor socio-economic status 
than the other 3 groups*
3* In the first continuing pregnancy these women
have a higher incidence of threatened abortion
and premature labour. Their perinatal mortality 
is increased due mainly to ^prematurity * and 
®foetal deformity®. They also have an increased 
incidence of operative delivery *
4. The group with 2 previous abortions have a
tendency to poor foetal growth and this is
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2*
associated with premature laboiir*
5# Worn cm v/ho abort in their first pregnancy have
an increased risk of abortion in their subsequent 
reproductive life*
0;# The recurrent abortion risk increases with
successive consecutive abortions from 2 5;.. after 
1 abortion to SB% after 3 abortions*.
7# One third of abortions occur before 2 months
gestation and 00% by 3 months#
8# In abortion studies the ®primary recurrent abortcr*
with 2 or more consecutive abortions should be 
studied* Observations must start before 8 weeks 
of gestation or earlier if a previous abortion has 
occurred before this time*
Chapter 3* Hormone assays in normal early pregnancy» 
in abortion and in hydatidiform male*
Î* Urinary pregnanodiol and oestriol assays are made
in 3 groups of women ( 0  Normal pregnancy 
(2) Nomen with at least 2 previous abortions and 
no successful pregnancies and (3) Women who aborted 
in the pregnancy studied*
2# There is no significant difference in oestriol
and pregnanedioi excretion between the women who
aborted and those in which the pregnancy continued 
successfully » until after 16 weeks of gestation*
3. These 2 assays are of no value in forecasting 
abortion until after 16 weeks of pregnancy*
4* The assays were perforned in 5 cases of
hydatidiform mole. In these cases the urinary 
pregnanediol and oestriol levels may be normal 
but are more likely to be low. There may be 
some change in steroid metabolism in this type 
of case.
Chapter 4. Conversion of progesterone to pregnanediol*
1. After the injection of lOOpc. tritiated progesterone 
the percentage radioactivity excreted as 
pregnanediol was measured in 4 groups of women
(1) Non-pregnant (2) Early pregnancy (3) Late 
pregnancy (4) Abnormal pregnancy.
2. There was a significant difference between the
results in abnormal pregnancy and the other 3 
groups. The percentage conversion was less in 
abnormal pregnancy especially in cases of 
hydatidiform mole.
3. There was no difference in conversion in the
same subject, non-pregnant and pregnant.
T 4 ■*
Chaptos'* 5* Progesterone metabolism in the human 
proviable foetwo*
1. Perfusion of previabio foetuses with 4-C^^
progesterone for M  and 45 min.* showed that
40% of the radioactivity is present in the liver
at 14 min* mainly as 20a dihydroprogesterone and
in the adrenal 3*4% of radioactivity^ is present»
mainly as polar compounds* After 45 min* the
main compound in the liver was pregnanediol and
in the adrenals* polar compounds probably
corticosteroid s.
2* The foetal liver is the chief site of progesterone
metabolism and this organ produces mainly reduced 
metabolites. The adrenal motabolises progesterone 
to corticosteroids.
3. Progesterone from the placenta is used by the
foetus to produce corticosteroids for its own 
homeostasis ®
Chapter 6* Steroid studies in a case of hydatidiform 
mole.
1. Th€^  urinary pregnanediol: pregnanetriol ratio in
molar pregnancy is 2 s 1 compared with 20s1 in 
normal pregnancy.
52* Mole tissue v/as Incubated vilth [4 - ^ G ] pregnenolone
as precursor p and 17co liydroxypregnenolone, 
progesterone» 16a hycU'^OKyprogeoterone and 10(3 
h yd r o xy prog eat ero ne v/er e Isolated*
o* ChoXestorolp pregnenolone* 17a hydroxyqjrcgnenoione, 
pregnanediol* pregnanetrio! and androstenedlonc 
v/ere isolated from extracts of mole tissue ami 
theca lutein cyst fluid: 17a hydroxyprogesterone
was isolated from cyst fluid but not from mole 
tissue*
4* Mole tissue is capable of steroidogenesis but 
there was leas synthesis of progesterone than 
normal•
5* The increase of 17a hydroxylation indicated by
the elevation of urinary pregnanetriol excretion 
is ovarian in origin.
Chapter 7* Urinary steroid excretion after gonadotrophin 
therapy*
Î* There is a significant increase in pregnanediol 
excretion in the luteal phade of the menstrual 
cycle due to the ovarian pa'oduction of 
17o. hydroxyprogesterono*
r»
if
6*
2* Urinary pregnanetriol excretion also E^ieea in 
the luteal phase of gonadotrophin stimulated 
cycles and in gonadotrophin Induced pregnancies 
until G - 8 weeks#
3v Measurement of this metabolite may be a valuable 
parameter of corpus luteurn function in the 
menstrual cycle, ami in early pregnancy#
4# This assay may bo of value in detecting
hyperstimulation of the ovaries by gonadotrophins. 
It may also indicate when the corpus lutcum of 
pregnancy is deficient and be of help in fore­
casting early abortion#
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iuetlea to t W  Theela
The theme of this thesis la "oorly prognaney^'# 
that la from ooooeptloa until obout 20 iveeke of 
ge&tatlon# This period Includes Implantation, 
placentation, the early development of tho footuo 
and of the footo-plaoontal unit#
The %vrltor*8 original Interwt, %vhloh led to thle 
study, was oonoorned tvlth abortion ana. In particular, 
%/lth the study of rootxrrent abortion* Much had been 
written, ohout mothoda whereby abortion eould be foreeaat 
but the reeulta were eo Ineoneleteiat that further 
Investigation eeomiod nooeeam'y. Although mueh resonroh 
had been devoted to the et%My of abortion, and a great 
volume of writings on the aubjeot had oeoumulated, 
undei^standlng of the proeeao had expanded little#
Thoi^o are a number of reaoone for this, not least of 
ivhleh, la the fact that much of the study had had, of 
neeeealty, to be oonduotod %vlthln the oontoxt and 
limitations of ollnleal medlolne* The selentlfie 
prlnelploe of oxmet definition of metorial, and of 
eontroia, have been largely ignored* Although widely
2h c e o p t W  definitions of abortion,
^Inovltabio* aboa'tion, r^nloood* abortion and *roeurMOt* 
abortion liave existed for dooadeo those categories 
have mot boon rigidly eeparated, and# In %vrltlng$ on 
the snbjdot thofo hoe boon inmfflolont dloorlmlnatlon 
between those ontltlw* For example# the moaning of 
r e o w r o n t  abortion 1$ not clear from the lltmatnre# 
and It ooomod probable that limitation of study of 
foonrrent abortion material to patienta %vho have had 
throe (rather than two) eonaeentlve ahortlow# %/ae an 
nnnoeeosarlly aevero reatrletlon ivhleh wan hamed on a 
taelt aoeeptanee of Malpas* (193$) formula#
It aoemod therefore* Important* In t&%e rirat 
Inetanoe to InveetlgnW the general Ineldenoe of 
abortion * ond ti%en to deter&WLne the reprodiactlve 
history of women wiio began ehlldbearlng with an 
abortion# This w o o M  give factual Information about 
the number %Yho aborted again and again* Indicate 
%vhether there was generally poor reproduction In these 
%mmcn* and the particular aspeeto of their 8%%bsoquent 
pregnnncloe to y^leh attention should ho paid during 
the period of antenatal care* It would# In imrtleular# 
help to define the type of woman moot liable to abort
I ,
again and also give information about the gestation 
period at which abortion oeenrred* It waa felt by the 
writer, that frequently, In therapeutic trials of drugs 
In reeuM^ont abortion# the drugs were given long past 
the gestation period at which abortion wao likely and 
that the pregnancies were already highly eoleeted by 
virtue of having already progressed passed this period*
The results of an Investigation Into these 
proh3.eais are reported In Chapter 2$ In this chapter 
some description of the oha%aeterlstlcs of the ivomen 
concerned, such as age, height and socio-economic group 
are discussed, and the problems associated with their 
next pregnancy are assessed with particular reference to 
perinatal mortality# Their later reproductive 
pattern Is reviewed, and the number of subsequent 
abortions Is compared with that In a normal group of 
women# The question of the gestation period at which 
abortion and especially recurrent abortions take place 
Is surveyed, and the chapter concludes with a 
dissertation on the implication of the results to the 
design of studies on abortion with particular relation 
to the gestation period at which therapy, if any, 
should be started and the women who should be studied#
4#
T W  demlgn evolved In Chapter 2 is then applied 
to tlw atudy of a group of mWrtlon prone women and a 
s W d y  la made to discover If the mea.surement of two 
steroid hormones# oestriol and prognanedlel. In the 
maternal w i n e  In pregnancy# will give any helpful 
Information about the likelihood of abortion occurring 
In these women* The reaeon why those two sterolde 
are moot likely to W  of value 1$ dlacueeed along 
with Information aho%:t their derivation and the 
metabollom of their precuraor## The chapter conclude# 
with u m m  observations on another abnormality of early 
pregnancy - hydatidiform mole - whloh is of particular 
Interest duo to the absence of the foetua In theae 
caoes#
The result# obtained In Chapter 3 pose a number 
of question# concerning progesterone metabolism and 
two of those are selected for further investigation 
In Chapter# 4 and 5*
In Chapter 4 the conversion of progesterone to 
pregnanediol la examined# The work in Chapter 3 
Bhowed a groat variation in pregnanediol excretion# 
and one of the poeelble explanations of thlo was that
there was a variability in conversion from the parent 
steroid to the urinary metabolite* The results of 
previous work on this aspect were confusing* The 
chapter begins with a review of progesterone metabolism 
in early human pregnancy* A description of the 
methodology involved is then given and the results 
are discussed*
The other appcct selected for intensive study is 
discussed in Chapter 6 on progesterone metabolism in 
the human previahle foetus* On a previous occasion 
the writer and D r , Klopper (klopper â 'Maenaughton 1069) 
had found pregnanediol in the liquor amnii* and the 
question of the metabolism of progesterone and the 
production of pregnanediol by the foetal compartment 
was another possible factor affecting maternal excretion* 
There %vas little information available at the 'time on 
this aspect, and perfusion experiments of previahla 
foetuses with radioactive progesterone were undertaken 
to elucidate the problem* The technique of the 
experiments and the results are discussed in this 
chapter*
I
As a result of the work on conversion of progeeter-
one to pregnanediol described in Chapter 4, women with 
hydatidiform mole were found to have lower conversions 
than normal women# The question of a different 
pathway of eteroldogenesla in these caaea was thought 
to be a posaible explanation# Steroid studies in 
hydatidiform mole were then unilartaken and are reported 
In Chapter 6» In these studios molar tlseue v/as 
incubated with precursor pregnenolone to determine the 
steroidogenic pathways In this tissue and ©taroids 
were extracted directly from the molar tissue itself.
The steroid content of the theca lutein ovarian cysts 
v/hioh are frequently present in cases of hydatidiform 
mole was examined and the origin of certain steroids 
such as hyd ro xyprogee terone ascertained# The 
results here do show a change in emphasis of the 
Steroid pathway in these women#
The findings of Chapter 6 are then applied to the 
measurement of the ovarian response in amenorrhoeic 
women being treated with human menopausal gonadotrophins# 
Chapter 7 discusses an investigation into urinary 
steroid excretion after gonadotrophin therapy# The 
stimulation of the ovary caused by gonadotrophins is 
not unlike that found in some cases of hydatidiform
molo a W  the particular use of pregnanetriol excretion 
in meoBuring corpus Intoum ftmotion in the monotruai 
cycle, end aioo in early pregnancy is ovaluateu# The
chapter conolWoa ivith a roforonoo to the poesiblo 
w o  of this oeany in forooaoting abortion# the original 
starting point of this thooia#
In each ohaptor t W  relevant litoraturo ia 
reviewed o%w tho relation of the ivork to that in the 
literature iB shown* Booh chapter diaouaaea a 
different aapoot of the overall theme and the relevant 
litoratnro and dleonaalon have W e n  inolWed ia% each 
chapter rather than in an overall introduction# In 
t%$i$ %my ropotition la avoided and the thoughts on each 
napset are kept together#
The purpose of this iE%troduetion is to show the 
relationship of the chapters to each other and to the 
overall theme of ea%*ly prognanoy# This theme i# 
illustrated by plates I VI# ivhleh are taken from 
*hr* aranvllle*a Graphic Illustrations of Abortion and 
%he Oiaeaaos of Menstruation* (1633)*
hCHAPTER 2 » 
studies on abortion and
Introduction
Much has been written on the probiem of abortion 
and ItB incidence (Malpao 1938} Bovis 1051} etc.) and 
there is confusion in the literature on the probability 
of abortion occurring in a subsequent pregnancy 
particularly in women who have experienced recurrent 
abortions*^ The theoretical calculations made first 
by Maipas ( 1038) and later revised by Eastman (1056) 
estimate the risk of spontaneous abortion occurring in 
women with a history of a given number of abortions.
Maipas considered that, after one previous abortion, 
the risk was 12^ ,^ after % previous abortions 38% and 
after 3 previous abortions 73%. These were revised 
by Eastman to 13, 37 and 84% respectively. These 
figures have been subjected to much criticism on the 
grounds that certain assumptions on which the 
calculations were based were faulty (Warburton â 
Fraser 1050} Qoldzieher ê ienigno 1068). Malpas (1038) 
for example, assumed that spontaneous abortions occur
0either for a eauee* or for a *non-recurront*
cause 1,0. that C % $ 0 0  of abortion can be divided Into 
a group with 100% chance of recnrrance and a grcnp 
with a chance of recurrance equal to the incidence 
of abortion (excluding habitual abortion) In the 
general population,
The gestation process depends upon such a complex 
interaction between maternal and foetal factors# both 
genetic and environmental# that it must be susceptible 
to Intorferonco by a very large number of agents and 
therefore Malpas* aeaumptlon is not valid. Results 
from these calculations have been v/lclely quoted # and 
have been used as controls in studies concerned with the 
prevention of habitual, abortion, James (1902) 
suggested that these calculations should be abandoned 
as they have been shown to be based on unreliable 
estimates of the parameters used.
It is the p%%rpoBC of this chapter to discuss the 
question of the incidence of abortion and to describe 
an investigation into the characteriptios of women who 
abort and their subsequent reproductive performance,
This investigation describes some characteristics of
10*
women who are more liable to abortion and indicates 
the important points in their subsequent reproductive 
life# As a result women at particular risk can be 
identified and attention directed to prevention of the 
special risks of their subsequent pregnancies such as# 
threatened abortion or premature labour# The 
Chapter concludes with a discussion on the relationship 
of the results to the design of studies on abortion 
and the particular pitfalls which should be avoided 
in such studies#
;0 of abortion
It is difficult# if not impossible# to obtain 
accurate information about the incidence of abortion 
for a number of reasons -
a)# In early abortions, before the placenta is well 
defined, the products of conception may easily be 
passed with little or no discomfort especially in a 
multiparous patient, and any bleeding may be mistaken 
for a menstrual period* There are considerable 
numbers of women who come to the gynaecological 
department with menorrhagia, discharge or staining, 
and are shown to have a *mi#»ed* or incomplete abortion
npreeenoe of villi aml/or deoiduai reaction in 
the endometrium when material, recovered at curettage 
ie examined hletoiogically^
b)# A numter of women# particulariv# it is prceumed# 
multiparae# have an abortion# usually early# which they 
recognise as ouch; but they are not ill and do not 
eeek advice*
c)# A number of women# with abortions# are treated at 
home by their own doctors and no record or notification 
of the event is made#
d)* There may be deliberate ooncealment in a number 
of cases %vhere the woman is not married or where the 
abortion is criminally induced#
It is thought# in the series described here# where 
the patients^ fi%*st pregnancies end in abortion# and who 
have recurrent abortions with no live children# that 
the information concerning the abortions ie likely to 
be more accurate than abortion information in general 
because the %vomen presumably want children# The 
exception to this may be the abortions which occur in 
later pregnancy numbers in which the question of 
induced abortions cannot always be ruled out#
32
Some data on the range of abortion incidente from 
U m  literature is given in Table I* Here the lowest 
ineidenoe is 7#<% (Tietzo et al# 1D50) and the 
highest IB*0;S (Mai pas# lûsa)* Mer tig and Livingstone
(1044) give a proportion of 1 0 * ^  ending in abortion 
of 1100 pregnanelea in private practice# Tietze and 
Martin (1957) found a rate of I7^ & spentanooiie and t9f^  
induced abortions in a sample of white married women 
of rather superior education* in the United States# 
Baird (195?) says that *the incidence of abortion 
relative to births at term is probably 1(% if criminal 
abortions are excluded* and Stallworthy (1955) gives 
a similar figure# Whitehouse (1929) in an invest- 
igation of SOOO hospital and private patients attending 
for gynaecological complaints found that 1972 of 11*430 
patients (1?#2$) had ended in abortion and the 
Interdepartmental Committee on Abortion (1939) 
estimated that for every 600*000 live births in the 
5 years proceeding their report between 110*000 and 
150*000 abortions occurred; of these the Committee 
estimated that 40)6 were induced#
Probably the most accurate incidence is that 
reported by Stevenson et al* (1959) from
IS
Belfast* In this study total hospital abortion 
admiseions wore obtained and to this waa added the 
numbers treated at home* aeeertained from information 
from fûiilwlvofâ and health visitors* and from the claims 
Of doctors for fees for treatment of abortions under 
the Northern Ireland Health Services Scheme# A most 
comprehensive sample was therefore obtained and an 
estimate of M $ 8 #  of all pregnancies terminating in 
identifiable abortions was arrived at# The writers# 
however# thought that the real frequency was probably 
somewhat greater than this# This magnitude of abortion 
frequency is Somewhere about the middle of the ranges 
shown in Table i # It is clear that there will be 
a wide fluctuation of rates depending on how a sample 
is obtained#
emiological characteristics and obstetric
per formance . of wom^n v/ho ,abort
Boureoe of Bata
In this study a number of different sources of 
data have been used ami these have been collated to 
make the resultant information as comprehensive as 
possible# While it is recognised that the main
diffiolilties discussed previously obtain* it is thought 
that the results given here are as aecurate as possible# 
By considering abortions occurring in the early 
pregnancies of women with no live children the points 
mentioned above are greatly obviâtod since the women 
are anxious to have a successful pregnancy# In the 
following series* however* where abortions are noted* 
it is possible that some of these may be induced and 
not spontaneous*
Five main sources of data have been used:- 
Group 3# Maternity Records of v/omcn having first
(7391) or second (53 70) pregnancies have been 
scrutinised# This group has been used as 
controls* Their obstetric performance has 
been compared with women who began their 
obstetric life with one or more abortions#
Group 2. series of ivomen (911)* obtained from 
Maternity Records* wliose childbearing life 
began with an abortion* The performance 
of this group in the second pregnancy has been 
compared with that of groups 1 and B»
Group 3* A series of women (104) taken from
agyaaeeological reeoNs* where the first 
pregnancy emlecl in abortion* These women 
have been foil.owed up for at least B years 
to determine their aubeequont obatetrio 
history and to compare it with group 4*
A oerieo of women (S3)* taken from obstetric 
records# v/ho began childbearing with a 
normal pregnancy and who were followed iip 
for a period of 10 yeara# This group has
been used aa a normal control for comparison
with group 3#
A aeries of women (129)# having their 3rd* 
pregnancy where the first too ended in abortion* 
This group has been used to illustrate any 
changes in obstetric performance compared
with groups 1 and 2#
In the tables# it v/ill he seen that the numbers 
in some of the groupe are not always complete* This
is due to certain aspects of the data being incomplete
in individual cases# These are relatively few in 
number and this does not alter the main trend of the 
results*
Group 04
Î 6 *
EpiclemiologAcal. Characteristics
In order to compare women who start childbearing 
with abortions and those who start with normal 
pregnancies the factors of age# height and husband*s 
Social Class are compared first#
Age - Table 2#
The group of women whose first 2 pregnancies 
ended in abortion contain a higher proportion of 
women over 30 years than any of the other groups#
This group and that with 2 normal pregnancies resemble 
each other most closely# The risk of abortion is 
said to be greater among older than among younger 
women (Tietze et al 1960)# Foetal loss in general 
tends to increase with increasing age of the mother 
after 20 years (Shapiro et al 1962) and these workers 
also showed that women whose last pregnancy ended in 
a foetal death have twice as high a loss rate in their 
next pregnancy as other women# When the incidence 
of abortion is related to marriage duration and age an 
increase is found in women over 26 years (Table 3)* and 
the National Statistics for England and Wales show a 
steady increase of childlessness with rising age at
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marriage* ChilcUessnass in this sense includes 
women who have both abortions and foetal deaths and 
who have no living children* The classical studies 
of Louis Henry (1953) showed that* in a society not 
using modern contraceptive methods - nineteenth 
century England - the probability of having another 
child was related to the ago of the woman and not to 
the number of pregnancies she had already had* More 
recently McKeown and Record (1957) have shown that the 
proportion of women becoming pregnant again within 
Z years of their first baby diminished with increasing 
age* There is much accumulated data showing the 
dilaterions effect of age on the reproductive process 
and this effect is again shown here in connection with 
women who start their childbearing with 2 abortions 
(Baird et al 1958)* The association of age and 
abortion was recognised many years ago by Burns (1843) 
who stated that ’*advancement in life, before marriage* 
is another cause of frequent abortion, the uterus 
being then somewhat imperfect in its action*
Height - Table 4*
The features of this table are the differences in
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stature between the women who have 2 abortions and those 
in the other 3 groups# one third of women with 2 
initial abortions are under 5*1" compared with one 
fifth in the other 3 groups* At the other end of 
the scale ZQfa of those women are over 5*4" compared 
with at least 26$ in the other 3 groups*
Husbands Social Class - Table 5*
This table shows that women in the 2 abortion
group have a higher proportion in social class 4 & 6 
than in the other groups*
Height and social clues taken together are a
well recognised measure of physique and general health*
A persorfs height is determined by both genetic and 
environmental factors; to attain one’s potential# 
adequate nourishment is required at all stages of 
growth including that in utero* Maternal stature has 
a strong association with social class and Table 6 
taken from the Perinatal Mortality Survey shows the 
distribution of maternal height within socio-economic 
groups* The proportion of women under 62" is 
greater in social class IV and V and least in 
social class I and II so that there are more short
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women as one goes down the social scale* The effect 
of height and soclo-econqmic group on perinatal 
mortality is also ivell known and Table 7 from the 
2nd# Report of the Perinatal Mortality Survey (1969) 
aho%ys this clearly* The lowest perinatal mortality 
is in tall tvomen in Social Cl as a 1 and the highest in 
small ivomen in Social Class IV and V*
The results of this study indicate that women 
starting their childbearing with 2 abortions are 
likely to he smaller and of lower socio-economic status 
than those in the other @ groups shown*
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women having their first normal pregnancy and a series 
of women whose first pregnancy ended in abortion# 
taken from group B$ are compared by duration of
marriage (Table 8 )•
Almost half (49$) the %vomen v/ho begin xvith an 
abortion complete this pregnancy within one year of 
marriage compared ivith 42$ of women who have a 
legitimate first birth# The cumulative total shows
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that there Ib little difference between the two groups 
at the 6 year period# These findings are not surprising# 
The majority of women# whatever their social class 
Conceive within 1 year of marriage (Ilisley 1056) and 
if abortion should occur it will he completed within 
the year# whereas if the pregnancy continues the 
delivery will not occur within the year from marriage#
Obstetric performance in first continuing pregnancy
The next aspect to he considered is how women# who 
have started their childbearing with an abortion behave 
in their first continuing pregnancy# In Table 0 the two 
groups of women who begin with Ï or Z abortions are 
compared with 2 normal groups# The particular aspects 
considered are# threatened abortion# antepartum 
haemorrhage# prematurity and perinatal mortality#
Threatened Abortion#
The table shows that there is more threatened 
abortion in these continuing pregnancies in the 
abortion groups than in the normal groups# This is 
particularly marked in women whose first two pregnancies 
both end in abortion suggesting that in these women
21
t h w o  is a particular tendency to early pregnancy 
blooding#
Antepartum Haemorrhage#
There is little difference in the incidence of
antepartum haemorrhage in the groups# The figure 
of 3fl$ found In women having a third pregnancy after 
two previous abortions is very close to that of 3#0$ 
found in a survey of single pregnancies by
Paintin (1002)#
Prematurity,
There is also a tendency for the number of 
premature births to ho greater in the women ivith 
% previous abortion and this trend is more marked in 
vfomen having their third pregnancy where the first two 
ended in abortion, Prematurity is therefore commoner 
in pregnancy when abortion has occurred in the previous 
pregnancy# To distinguish between prematurity due 
to the "small for dates" or poorly groivn baby# and the 
baby that is normally grown for the gestation period# 
but is delivered early# the weights of babies at 
various gestation periods in the four groups of cases 
were examined (Table; W ) #  Babies born to women in
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both previous abortion groups up to 35 ivoeks of 
gestation seam to be smaller than in the other two 
groups# This may mean that pregnancies in these 
groups terminate at an earlier stage of gestation* 
However# women in their third pregnancy with Z previous 
abortions have babies at least half a pound lighter 
than any of the other groups at the 3 6 - 3 7  week 
period#
Thé proportion of deliveries occurring before 
36 weeks of gestation is considered in Table 11#
There are more deliveries before 3 6 weeks in both 
abortion groups than in the normal groups and this is 
particularly so in the group with & previous abortions 
where it is double that found in normal primigravidae#
These results show that women who begin their 
Childbearing life with two abortions have an increased 
risk of premature labour* The women who have 
premature labour also have email babies for the gestation 
period and these babies are therefore *small for dates’# 
There are a number of possible actiClogieai factors#
In some cases a uterine factor may operate# This may 
be a uterine abnormality which can be easily detected
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on hystcrography# Another possible explanation la 
that of Inadequate uterine accommodation which is well 
documented In animals Reynolds (1959) but very 
difficult to prove in the human subject* There is a 
Very constant relation b e W e e n  the uterus# on one hand# 
and the size of its contents on the other* The 
uterus affects the also of the offsp&^lng and the size 
of the offspring affects the uterus* Reynolds (1959) 
noted that# as the last phase of uterine accommodation 
becomes established the contents of the uterus outgrow 
the confines of an increasingly unfavourable uterine 
environment and either parturition or foetal death is 
the inevitable climax* It seems possible that In 
this group of women there may be a fault in uterine 
accommodation leading to inadequate foetal grotvth and 
premature labour*
It has also been sho^m (Baird I§5.3;) that the 
incidence of prematurity is related to social class 
being highest in the# lower socio-economic groupe*
This seems to be a factor in women having two initial 
abortions. It is not the whole answer since a 
number of women with a good #oeio-economic history 
also have premature labours and poorly gro%vn babies*
24
Here the effect of age on the reproductive process 
may be important since these women are on the whole 
o M e r  than those in the lower socio-economic groups* 
fioM (1061) has shown that some mothers repeatedly 
have premature babies# The tendency to repeat 
unsuccessful pregnancies is also higher in women who 
begin childbearing with one or two abortions. It is 
of prime importance to monitor foetal growth wlth care 
during these pregnancies. Although poor foetal growth 
can be detected clinically the use of urinary steroid 
analysis (Macnaughton 1067) or ultrasonic techniques 
(Willocks et al 1067) are particularly helpful in 
management of these cases. If deficient foetal growth 
is detected it ia these women who are also more likely 
to have premature labour,
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The main difference between the abortion and 
normal groups in Table 0 is in perinatal mortality.
In the abortion groups# the rates for one previous 
abortion and two previous abortions are 43,2/1000 and 
38,8/1000 respectively compared with 30,7 and 20,9 in 
the first and second normal pregnancy group.
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flio aaueée of these deaths have been analysed 
and classified by the method of Baird et ai (1064) 
and the results are shown in Table 12* In the ease 
of the group of third pregnancies with 2 previous 
abortions# numbers only are given since these are too 
small to make percentages meaningful. There are two 
main causes for the increased perinatal mortality, 
file number of deaths due to prematurity and foetal 
deformity are considerably greater in both the previous 
abortion groups, Seven of 26 deaths in the I previous 
abortion group and I of B in the 2 previous abortion 
groups were due to prematurity and 7 of 26 deaths in 
the former group were due to deformity. In the latter 
group 3 of B deaths were due to foetal deformity - a 
high proportion.
The cause of most foetal abnormalities is obscure. 
Indirect evidence suggests that foetal defects may be 
brought about by inadequate intrm uterine environment. 
Abnormalities of implantation are associated with a 
high incidence of malformation (Hertig 1967) and it is 
well known that in many early abortions the foetus or 
the fertilized ovum are abnormal (Hertig and Rock 1944),
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There is an Increased Incidence of foetal abnormality 
if bleeding has occurred In the early months of 
pregnancy (Turnbull and Walker 1956), It seems 
likely that the faulty intrauterine enviroiiiment ivhlch 
leads to deficient implantation and development with 
resultant abortion in the first one or two pregnancies 
In the abortion groups may be present to a lesser 
extent in the next pregnancy* It may be insufficient 
to precipitate abortion hut sufficient to Interfere with 
normal foetal development thus resulting in foetal 
abnormality.
Performance in labour
The four groups are considered by Incidence of 
Caesarean Section# forceps delivery# assisted delivery 
and spontaneous delivery (Table 13 ), There is a 
slight increase in the number of Caesarean sections 
in the 1 previous abortion group and this rate of 5,9$ 
is doubled in the 2 previous abortion group. More 
forceps deliveries (19,6$) were done in the 1 previous 
abortion group than in the normal group but this %va8 not 
80 in the 2 previous abortion group ivhere the main 
difference was in the number of Caesarean sections
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performed* Table |4 the indications for
Gaosarcan section in the third pregnancy of the
2 provioun abortion group are given* Fourteen 
women were delivered by CaeearOan section# In 
7 of thoBC (50$) the operation was elective and 0 were
oyer 30 years of age# Other reasons for aeetion were
placenta praevia CO.# Breech presentation (1)# Foetal 
distress (3)# Incoordinate uterine action (1) and 
Disproportion (1)#
These increased operative delivery rates.reflect 
the desire of the attendant to minimise delay in 
labour and not to ’take any chances’ with the baby#
In most cases where the obstetric history is poor there 
is an increased incidence of operative delivery#
In the Caesarean Section group the factor of age 
is particularly evident and 8 out of the total of 14 
women were over the age of 30 years. In all but one 
of these ivomen the Caesarean section %vas elective because 
of the combination of bad obstetric history and age*
The other interesting feature of these women is that only 
2 of the total were over 5 ’4" in height# They were 
almost all medium (S’f* - 5*4") or small (under 5*1")*
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Thi8 is a highly selected group %vith a large 
proportion of short women# The combination of 
small stature# relatively old age and a history of 
previous abortion make the likelihood of Caesarean 
Section very great in these immen#
There are still# in spite of the adverse history# 
a relatively large number of women in botli abortion 
groups who had a spontaneous delivery although the 
number is lov/er than in the normals#
Fertility following first pregnancy
In Tables 15 16 the fertility of women following
a normal first pregnancy is compared with that of 
women whose first pregnancy ended in abortion# In 
the first table (15) the number of subsequent children# 
the number of unsuccessful pregnancies over 28 iveeks 
and the number of women who had abortions only 
following the initial pregnancy are shoim# The detailed 
data about abortions are shown in the second table (
Nearly 8$ of women who aborted in their first 
pregnancy had abortions in all their subsequent 
pregnancies # whereas no woman whose first pregnancy was
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normal had abortions In all tbelr subsequent 
pregnancies* Two women In the first group did 
carry pregnancies past 28 weeks but these were 
unsuccessful# Therefore 10$ of women in the abortion 
grotip had no subsequent successful pregnancy compared 
with none in the normal group* The number of women 
in the normal group who hod no further pregnancies 
after the first one was double that in the abortion 
group* The total number of women having abortions 
during subsequent childbearing in the abortion group 
is 36*6$ compared with 20*5$ in the normal group*
There eeems little doubt that when a woman begins 
childbearing with an abortion a greater number of her 
subsequent pregnancies will end in abortion than when 
her initial pregnancy ended with a live child. Very 
little information is available on the subsequent 
pregnancies of women who initially miscarried. 
According to the data of Whelpton and Kiser (1948) 
approximately 75-80$ of women having an initial 
miscarriage will eventually have a potentially viable 
foetus of 20 or more iveeks gestation. This is not 
very different from the figure of 83$ obtained in this
so#
study# The remaining 17$ consists of approximately 
7}<i who had no further pregnancies, 8$ who had nothing 
but abortions, and 2$ whose pregnancies continued past 
28 weeks, but where the baby did not survive.
Eighty-five percent of women whose first pregnancy 
was normal had further live children but the remainder 
had AO more pregnancies# None of the 83 patiente 
in tills group had any subsequent abortions or premature 
labours. The fact that 14#5$ had no further 
pregnancies is unusual. The reasons are not clear.
It is not solely an age phenomenon since of the 12 
women, 6 were over 30 years and 6 were under 30 years 
at the time of their first pregnancy# This 50s 50 
ratio does show that an unusually large number were 
in fact older at the time of their first pregnancy and 
may not have desired or been able to have another child 
These women were all followed up for 10 years so it is 
unlikely that they would have another pregnancy# It 
is of interest here to recall the views of Matthews 
Duncan (1871) who enunciated what he called his * Law 
of relative sterility’# This was# of course, in an 
age of no contraception but it may be still partially 
true# The law states that *a wife, who, having had
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ohlldran# hao ceased for 3 years W  exhibit fertility# 
ham p*;*obably become relatively mterilo; that is will 
probably Oaor no more children# and the probability 
inereaoos am time elapses’#
The %voman with repeated abortions does not have 
difficulty in becoming pregnant but in ’holding on’ 
to the pregnancy# The findings in thia study support 
the view of Javort (#957) who also said that fertility 
wee not redneed in theme women# They do not hear 
out a oommogily held opinion that women %vith a history 
of repeated or spontaneon# abortion have a lox/ overall 
fertility (Donnelly and Locke 1053)# The repeated 
abortion rate in sterility patiente (((%) reported by 
simhcig at al ( 1952) is not very much above that in 
’non-eterile’ patients#
It does not eoem that there is a general close 
relationship between abortion and sterility#
The number in the abortion group who aborted 
again in aaecoseive pregnanciee io oho%m in Table 17# 
Analysio of these résulta ehowe that there is an
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increasing abortion rate in this type of woman# In 
the second pregnancy with one previous abortion the 
rate was 25$ which is not so very much greater than 
the incidence of abortion for first pregnancies, 
in the third pregnancy with two previo%is abortions 
the rate is almost doubled to and more than half
(58.3$) of those women who have aborted three timee 
aborted again in their fourth pregnancy,
The results show that the main increase in 
abortion probability occurs after 2 successive 
abortions and therefore# if abortion prone women are 
being selected for study it is unwisc to restrict the 
study to women who have had 3 or more recurrent abortions 
as suggested by Malpas (IMG), This view is also
expressed by the Council on Pharmacy and Ohemistry 
of the American Medical Association (1940), Ooldaiehcr 
and Uenigno (1966) and Roberts (1964)# There is# 
however# a wide scatter of probabilities in the 
literature (Table 18). This wide range of recurrent 
abortion frequency suggests that the published 
material is quite heterogeneous and that for more 
accurate studies individual control groups must be
used. James (1963) noted the high varlanees seen 
In the observed distributions and sitggested that the 
abortion probability ohouid remain relatively constant 
within each woman; if it had varied thia would have 
reduced the variance (Edwards I960). It aeeras likely 
that abortion pi^obabilitiea do# in fact# vary from 
one woman to another although not appreciably within 
a given woman# This, of course# does not deny that 
in a few cases abortions are asoociated with blood 
group incompatibility and that the probability of 
ieo-immuniaation increaeea ivith gravidity (Glass 1040)#
Gestation Period of Abortion
The results of an analysis of the gestation 
periods at which abortion occurs are shown in Tables 
10# 20 and 21# About one third of abortions take 
place before 2 months gestation and 60$ have occurred 
by 3 months# It seems iiZcely that many of these 
early abortions may have a chromosome anomaly. Carr 
(19G7) found that the mean duration of pregnancy for 
44 abortion specimens with chromosome anomalies was 
85.9 days from the first day of the last menstrual 
period to the day of abortion* The mean gestational
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eg© for 144 abortions with normal chronioeomes vms 106.7 
days. It is probable that women who abort early in 
pregnancy are more likely to do bq ûite to a foetal or 
ovular abnormality and those abortions which occur 
later are more likely to be due to some utérine or 
environmental factor. When therapy is considered it 
should be remembered that 50$ of women abort after the 
third month and that the clangor of abortion ia not over 
by this time.
Women who abort in succeasiva pregnancies show 
the same pattern except that those having a third 
auceesBive abortion tend to continue their pregnancy 
for slightly longer. It ie possible that these women 
are subjected to more care during this pregnancy in 
view of their previous obstetric history# and that 
continuation of their pregnancy for a longer period 
may be due to this care#
If the gestation period of the second abortion is 
compared with the first (Table 22) in the same woman, 
between one half and two thirds of the women will 
abort at the same time in the second pregnancy as in 
the first. This means that there is a strong
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teudenoy for women v/ho are abortion prone to abort 
at the same gestation period in a subsequent pregnancy.
The relevance of these roBults to the design 
of studies and the use of therapy in recurrent or 
habitual abortion will be discussed later.
Interval between pregnancies
The interval between pregnancies in women whose 
first pregnancy is normal compared with women whose 
first pregnancy ends in abortion is shown in Tables 23 
and 24. Half of the woEien (50$) in the abortion group 
have a second pregnancy within a year from the time 
of the abortion and 80$ have a third pregnancy within 
Z years compared with 17$ and SB$ respectively for the 
normal women. In the abortion group 92$ of women 
have had a second pregnancy within 5' years whereas only 
73$ of women starting with a normal pregnancy have a 
second child within this time. The picture is the 
same when the interval between second and third 
pregnancies is considered (Table 24).
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beare out; the (^ r^ovJLous finding that women 
who abort are not Infertile^ Indeed their fertility Is,
If anything# Increased# It la not that they are 
nnable to become pregnant ae enggeated by Qottmaeher 
(19 86) but that when they do achieve a pregnancy It 
does not continue to viability*
Age a%id Duration of Murrlage
The incidence of first abortion Is greater over 
the age of yenro than under ^8 years for all mar&'lago 
durations (Table 3 ) #. but particularly so after marriage 
has lasted for over 5 years whan the rate is more than 
double that under years for the same marriage 
duration* Guttmacher (H98G) shov/ed that when 
Contraception Is not practised **There Is a detrimental 
effect of Increasing age on fertility"* These findings 
substantiate the results discussed on page #Gsho%vlng 
the del^eterlous effect of age on the reproductive 
pro^gess* Guttmacher {#986) has also shown# that age 
and a prolonged state of matrimony were separate anti** 
fertile factors* no was surprised to find that the 
time required for a first conception Increased by 
seven hundredths of a month for each year of the wife^s
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age and almost tv/o fifths of a month for each year 
of marriage# The explanation of the effect of age 
and cUiration of marriage on abortion and fertility 
are no doubt compicK and certainly obscure*
Relation of results to the design of abortion studies
There is so much variation in the design of studies 
on abortion that the results are seldom comparable*
One comrrton error is that ’Primary habitual aborters*# 
women who have had 2 or 3 consecutive spontaneous 
abortions beginning with the first pregnancy are 
confused with ’Secondary habitual abortors’# a term 
which designates those women who have had throe or more 
consecutive spontaneous abortions following delivery 
of one or more ionuature# premature or full-term infants 
(Javert et al 1949)*
The two main points brought out by the present
work are -
(1) The typo of patient that should be studied and 
The gestation period which should be studied*
a .  fy.m. of pafcionfe
The classification of patients liable to abortion
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has given rise to mueh discussion (Goidziehcr and 
Bonigno 1958). The term ’recurrent abortion’ is 
frequently used to describe ivomen %vlio have had three 
or more successive abortion$(e*g* Maipae 1838# Speert 
#884# and others)* it ia# however# apparent from 
the present work that immen who have had two abortions 
are likely to abort again in 40^ of cases and that 
these %vomen should be termed ’recurrent aborters’ and 
placed in the ’abortion prone’ group (James 3963)#
It is important to exclude women who have had only one 
abortion# Many first pregnancies end in abortion 
after which further pregnancies are successful (over 
SÛ|â) * Subjects with only one previous abortion are 
therefore a heterogeneous group in which the recurrent 
element is minimally represented# Subjects who have 
had one or more viable pregnancies interspersed with 
abortions (secondary recurrent abortion) are likeivise 
a mixed group and unsuitable for comparative study# 
Ideally subjects with four or more abortions are the 
most suitable group to study as the abortion rates in 
this group are considerably higher than those with two 
or three previous abortions and the results of therapy 
would therefore be easier to evaluate# The numbers of
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tliese patients# however# v/liich present at any one 
clinic are very small*
Threatened abortion may# in practice# be very
difficult to distinguish from inevitable or miseed 
abortion* Studies on threatened abortion (Colvin 
ot ai #50; Goldzleher and Beriigno 1058) have not 
proved very useful in diseriminating between successful 
or indifferent treatment or supplying information as 
to the cause of abortion* Much the more promising 
group in this respect would appear to be the primary 
recurrent abortion group with two or more previous 
abortions*
2)* Gestation period to be studied
«STirajiqt’OtïAa S:i«mtnaaiUFiit K«»a>anwjw*iu»"(5»
Little attention has been paid to defining this 
aspect of the problem* In his monograph on 
’spontaneous and habitual abortion’ Javert (1957) 
barely mentions gestation period even although the 
question of therapy in habitual abortion is widely 
discussed*
Most workers have commenced studying patients at 
varying stages of gestation without any raferenco being
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made to the gestation period at which previous abortions 
had occurred. It has been shown hero that one third of 
abortions take place before two months of gestation and 
50/j have occurred by the end of the third month. 
Furthermore between one half and two thirds of women 
abort at the same gestation period in subsequent 
pregnancies. This suggests that initial observations; 
in abortion studies must be made at the latest by 
8 weeks g and any therapy being used should have started 
by this time. If a previous pregnancy has ended in 
abortion at an earlier stage than 8 weeks# this
earlier period should be taken as the time by which
initial observations should be made. If# for instance# 
observations# and/or therapy# are started as late as the 
14th week of gestation (Goldxieher 1964) it is highly 
probable that these subjects are already naturally 
selected against abortion and this tends to vitiate the 
trial of therapy*
A. further point which has to be noted is the time
at which women normally present themselves at the
antenatal clinic for the first visit. Scott et al (1956) 
have given some information on this aspect* They found 
that# in Aberdeen# 35^ 6 of women with two living children
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attended for the first time after the 20th week of 
pregnancy as compared ivlth of women with one child 
and 12^ of childless women* Women with the eame number 
of children attended earlier if their previous pregnancies 
had ended in abortion or etillhirth showing that patients 
who have reason to fear complications consult a doctor 
earlier in pregnancy# This tendency was found $e he 
amre pronounced among women who had had previous 
pregnancies ending in abortion than in women %vho had 
stillbirths or whose children had died auksequently,
In spite of previous abortion# however# the average 
week of first attendance in multigravidae ivith no 
living children was 12*6 weeks* It is quite evident 
therefore# that special arrangements muot he made to 
see cases for abortion studies early in pregnancy before 
they normally attend the antenatal clinic*
This study shows that when a %voman a tarte child"* 
hearing ivith an abortion her subsequent reproductive 
behaviour is different# with more complicated pregnancies 
and a higher rate of foetal loss than a woman who starts 
with a normal pregnancy* These women therefore# form a 
group requiring strict antenatal supervision in all
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.subsequent pregnancies so that the foetal loss can 
bo lessened*
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hormone assays in normal early prej^nenoy;» 
in abortion and la hydatidlform mole
la compter 2 it woe aoggomted that once a woman 
had had w o  obortiona %vithout any 3.ive ohlldi-^ en she 
ahould W  placed In an abortion*" pro no group* This 
ohaptex* %vhlob deal® ivlth steroid aseaya In abnormal 
early pregnaney# atemo directly from this %voTk* The 
objeet h w e  to dlsoovor the value of certain 
8tm old assays In the management of rooora'ent abortion 
and to agacer tain what happens to the hormone levels In 
thla type of oame*
The two main storoida to be oonalderod in the 
flrüt Inatanee a%*a ( U  p&'^ognanadlol {Sp^ p^rognano'^ '^ G,"" 
^Oo.'^ diol) and (2) ooeW'lol# one of the three elaaoloal 
0eBtroge*%e (ooetradlol IZp# ooatrono and ooetriol)*
Both thogge aubota;ieos are excreted In the urine In 
pregnancy and some Initial observations will bo made on 
their derivation and metabollem#
4-4" #
1. Progaancdlol
This compound is a ciharaeteri^tic metabolite of 
proge.atcrono and v-ms Isolated from lato pregruiaey 
urine by Marrian in 1D29# In 1034 Butenandt and 
Schmidt domonatrated a connection hetwoon pregsuniedioi 
m û  tyl'io activa hormone progcatcrono by aysithosieing 
tho latter from progaaiiadiol* _ In 1030 Odell m û  
Mar.rino oxtraotcd a combined form of pregnanodiol from 
pregnancy urine# They noted that the free storeid 
CO aid be obtained By hyclroiysie of this compound with 
hot acid# In the oamc year Vanning and Browne ( 1030) 
isolated the sellable combined form of
prcgnanodiol from butanol extracts of into pregnancy 
urine# They wore able to show that It v/aa present 
as the monosodium aalt of prcgnancdlol glucuronic acid#
In 1837 Vennixig et al demonstrated a physiological 
connection between progesterone and prcgnanediol by 
isolating the latter from the urine of subjects 
injected with progostaroac and of normal women in the 
luteal phaso of thoir menstrual cycle*
The relationship of progoatcrono to prcgnancdiol
in the human and the recovery of urinary piognanedlol
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after t W  Injection of p r o g w W r o a o  will be dlecussed
in detail In chapter 4*
O M a w  prodnelng pregnanedlol precursor la pregnanev* 
Orgaw producing pregnanedlol precursor la pregaancy*
A* Ovary* Progesterone la produced by the corpus 
lutearn la the ovary and ha® been Isolated from 
this tissue* (Batcaaadt ot al $934g Bhort 1902)#
Placenta# Prcgesteroae hae been Isolated from 
W m a a  placentas (Pwrlmaa and Oercco# #02b)#
Tlsauc culture eapei'^lmeats eaggeet tliat It is 
p%^oducW by the syacytlotrophoblast and most of 
the pregaaaedlol found in late prcgaaacy urine 
originates from placental pi'^ogeeterone# Some 
metEiholiam of progesterone occurs la the foetus 
(see Ghapter 8)^ and pregnenWlol he$ been 
isolated from the foetal livw# That the foetua 
might exwete pregnanediol in the 'urino seemed 
likely following the finding of this compound la 
the liquor amni by Klopper and Macnaughton (1959)* 
Borne of the pregnonediol in the maternal urine in 
late pregnancy is almost certainly of foetal origin 
hut eiace foetal death i^eeults in very little if 
any reduction in pregnanediol excretion in the
46*
In t W  maternal the amotmt must be small
(Bolomoa #9 66 "* poMonal communication)*
C* Adrenal* A significant, fraction of the
prognanedlol normally present In the urine has 
been shovm to come fromi the adrenal gland# and 
%o r e  la an association between the levels of 
%%rlnary pregnanedlol and the physiological activity 
of the adrenal (Klopper ot al #807)* In fact 
most of the pregnanedlol preecnt In the urlno of 
poet menopauoel women comes from the adrenal gland*
Pregnanedlol la therefore' derived from prccnrgior 
$yntW$lscd In these three eltee and the quantitative 
rolatlonahlp howeea progesterone p^-'oduetlon and 
motabollte excretion will be dlocueaed In Chapter 4 
together with further notea on the metabollom of 
pr
^egnanedlol exc»'otlon In normal pregnancy
Tahle^^ from the pa%>er by Klopi^or ^ Blllewloa 
(##63) ehowa the steady rise In pregnanedlol exorotloMi 
throughout a o M a l  pregnancy* in the present context 
only the levolo up to #0 %meko gestation have been
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given as this is t w  period of prognancy being
particuiarly stWiod* Those M s u i t s  agree iveii 
with these of shearman ( 1950) using the seme aesny 
technique*
2 * oe@triei
During pregnancyg ineroaaing amonnte of oestrogew 
ere excretw in the maternai wi n e  end it has been 
eatebiiahed that the piaeentn is the mein eoweo of 
urinary oestrogen In the pregnant woman* The evidence 
for this view is adequately summrioed by Dic!sfaitmy & 
Trooa (#6#)* Although a large mmber of different 
oeetrogons are found in pregnancy urine (Brouer #064)# 
not all of these appear to he manufactured in the 
placenta and consideration 1® tmually centred on the on 
onllod cluaalcal ooetrogena oeetrone ocnt%^adloI #70 
and oc$trlol# These aubstancee» and particularly 
ooatriolf^ have been most iatenulvoly studied in 
practice*
It waa assumed at first that the human placenta# 
like the ovary# could mynthesiae ocatrogen® from
4*6 «
acotato# S M m o  tho conversion of aeetate to urinary 
ocatrogan had W e n  domonetratod in tîio pregnant mare 
(iVarlKin at ai 1057} arul tlto conversion of radioactive 
oholeatarol to urinary aoatrogon In a pregnant woman 
had also been reported (tevlta at al 1902)* It is 
not poaaihlo# however $ to domonatrato in vitro tho 
placental eonvorsioii of acetate to ooatrogen# and 
thQ clioproportionatoiy large amunnta of oostrlol found 
in late pregnancy cannot be explained by the placental 
metaholiam of oootrono or oestradlol heaannc the 
necessary 16a hydroxylation reaction ia inefficient in 
th.o p 1 a0 onta (hevita et a 1 1062} * Fnrthermere it 
has become evident from tho atudios of Fraudéon and 
8takeman (19 03) and Caoemor (1909) that the foetus ie 
ossantJLal for maximum oestrogen production*
It aoaiïio true limvcvar# that the placenta does 
secrete oostriol' aince the concentration of total 
ooBtrio.1 is higher in uterine venona blood than in 
maternal arm vein blood (Eoy 10(>2)«^  The increaaeti 
urinary excretion of oestrogens during pregnancy closely 
parallels the increase in placental weight and^ after 
removal of the placenta the oestrogen excretion
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rapidly (Brown #907) # The %)lac0nta 
produce® the three ’elaesleal’ oMtrogon®# oe$trane$ 
oe^trWlel #70 and oeetrlol ^ t W  laat eompound Being 
m a n n f a e t w W  In the largest amount*
The placenta appeara to be capable of producing 
oastriol 1 B J Ü Ü &  ii»Siî£S. (Rya« 1»60)» but not by 
^yntheela from acetate and eholeatorol* placental 
perfusion or Inenbatlen %vlth labelled acetate and 
eWleatorol (tevlt)% ot al #062) did not ehow the 
formation of oeatrogona; but after perfwelon of 
term placentae 1^ (Warren & Tlmberlake# #964;
Oodard et al #002) and midterm plaeentaa ln.^8,(^q 
(Balte et al #0B4a & b)# teatooterone and othei^ neutral 
C^#B aterolda have Bean transformed Into the 
oorreapondlng oeetrogmia# The eomblnod aetl%^ltles 
of foetus and placenta convert non oeotrogenlc oterolde 
to oeatro&ens and this ia on Important oource of 
oestrogen in prognanoy# (Mltcholl# #907)*
garly In normal prognoney a largo fraction of the 
amall total amoant of oeatrlol present la derived f»x)m 
aoureea aueh aa ovarian ooatradlol* Aa pregnancy 
proeooda this fraction deereasea and at team amounts
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to only about 10;% of total oeotrlol production (Siiterl
aua UacBmntlii 1900)#
PrmiûBon atiû Stakamon ( #00# # 1D63) first suggest act 
that tho foetal adrenal might supply an oestrogen 
proaarsor to the placenta* fho work of Bauliou and 
Bray ( ID63)# SiltorA and MacDonald (1065) and dolte 
et ai (S864i>) oh owed that dohydroopiandroateroiio 
railphato (l>IIAB) which is ciranlating in pregnant women 
is converted to urinary oostrogeno $ High concentrât*"
ion G of DEI AS have heoii found in cord blood ( Simmer ct 
al #064; {^borloin 1965)# supporting the oaggestloa that 
this oestrogen precursor may bo produced in the foetal 
adrenals* The DHAS ivhlch roachon the placenta via 
the umhiiloal circulation is converted to urinary 
oontrogen (Delto ot al# 1D04B); it ie reduced at G""17 
anû 10% hydroKylatod mainly in the foetal liverp (little 
16a, hydroxylation take® place in the placenta)*
Once aostriol has been formed by the placenta 
some reaches the foetus# where it is converted into 
the corresponding 5-nulphato* The oostrlol-s- 
aiilplmto formed is returned to the placenta# where it 
io# in part# hyclrolyned by the aryleulphataoe ai
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liberated oeetrlol lo returned te the foetal and 
maternal compartment®* In the mother thle oeetrlol 
I® conjugated ivlth the 3«^8ulphate and glueoslduroEiate ^
and excreted* The metahollam of oestrlol in both 
maternal and foetal eompartments Is characterised 
mainly by GhaEnge® In conjugation and not in the ateroid 
moiety (Dlc%faluay ê Benagiano #D6G)#
Haynoa et ai ($964) otudied the metaboliam of 
ooatrmdiol"'4-G^'^ in %)crf%med footuaea and found that 
the major motabolitoe were oest%"adiol»»g'^0Ulphate and 
oeatrono*^3'"aulphatao They were not a$)ie to demonstrate 
the formation of oostrioi from oeatradiol in the foetus, 
FurW%ormore# t$ie perfusion of t$ie footo^piacental unit 
did not reveal the p&^eeence of any significant 
amount of oestriol# Ooetradlol# therefore# which 
reae$%eo the foetuo via the tmbillcal circulation# is 
not metabolized to oestriol to a$iy extent* Tliere la 
aiao little eonveralon of owtrone to oeetrlol alnoe# 
when the Isolated footna we# perfused ivltfi oeetronQ«»3"« 
oulphate# OEtly % small amount of oeotrlol was isolated 
(Bmerman et al $965).
Oeetrlol is man%%factured by the placenta from both
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foetal mid maternal p M c w s o r ® #  A foeto*»placental# 
eeBtrlel""3.«Guiphate cycle Is oatablishcd consisting 
of footal anlplmrylation and placental doznlphurylatlon 
(aoaiielemmnn et al# 1060)$ Soma ocstrlol**3"*aulphatc 
la oxoratad By the feetua In the n&mlotla sac (Troen 
1D01g Dlcafaluw at al 18#3; Kat% et ni 1985); It 
reaches the membranes tvhore It Is hydrolysed# the 
oeztrlol le liberated# and tranaferred to the maternal 
and foetal organleoa# The metaWllo pat W a y a  of 
ooatrogon motabollBm which occur in the footo^'piacental 
unit are haaloally duo to difforonooe in onxyme 
distribution between the foetue and placenta.
As a M B u l t  of the part played by the foetal 
tWrenal glande in supplying procorzor hydroxy#* 
dehydroopiandromtorone onlphato (DIIAB) for the placental 
olalmratlon of oeotriol# much of which is excreted in 
increasing mmounta throughout pregnancy in the maternal 
w i n e #  the moaaurement of ocstriol in the urine has 
provided a w o f u l  tool for measuring foetal vitality. 
Maternal u%\6 contriilmtee a relatively minor proportion 
of the total oeetriol throughout pregnancjf via both
03
noutraJl anü phenolic pathways#
Bariy in normal pregnancy a large proportion of
the total rvuiouat of oer:;triol lo derived from other 
aources poooihiy ovarian* with lengthening 
pregnancy this source decreases in importance# and at
tore BCp of the ocstriol ie formed in the placenta# 
mainly from neutral proeorsoro arising la the foetiia 
($iitori & MacDonald 1906)* If# therefore# t h w e  is 
any abnormality of the foetus# this may l:>o reflected 
in the oestriol excretion In the maternal urino*
This is supported hy^ the finding that ail the
oostrio.l formed by a woman with an an encephalic foetus 
appears to bo derived from maternal OliAS primarily via 
oestradlol (Siiterl atid MacDonald %D00)* When the 
foetUB in anoncephalic# the matornnl urinary aoatriol 
operation is one*-tenth of that found in normal pregnancy 
(Prahdecn and Stakoman 1903)# In these footuaeo tiic 
foetal cone of the adrenal gland ia small or absent*
Maternal ocatriol excrotion has also been shown 
to eorrciato with baby weight (Coyle & brown 1903;
F rand eon & V> t a hcman 1 i) 00) *
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main e W  product of the oeetregenG is
oej8tr,Wl and many worker® have been interested in the 
urinat^y entrât of thi® oterold in pregnency (Brown 1956; 
Zondek â Goldberg 1957; tantore 1808; Kellar et al 195D; 
F r a W e o n  & ztakeman 1D60; Nobkirk at al i960; Kaiser 
1060; Berth #eO; Klopper et al #001; Greene ot al 1061; 
Oorth 1061; Bnnerjen 1B02; Kobkirk & Nileen 1062;
Doling 1003; %Vray & Russell 100$; Ooyle ^ Brown 1003)# 
It i® difficult to compare the valnea obtained by 
different workers me their aeeay mothode# their 
criteria for normal p&^egnaney and thoi$^ experimental 
deeigno have been different# The paper® quoted 
repeint mean value® during the last month of pregnancy 
varying fro#^ U m g  (%ondek &Oaldbm''g #57) to 32îo$* 
(Keiiar et al 1059) per 24 hr®. It is not poeaible 
on the baeia of these publications to apeeify with any 
exactitude the ohangee in oestriol excretion during 
pregnancy W t  only the extent of variation to bo 
OXpOOtod* Ae with prognanediol the swinge of 
exorotioti from day to day in the same patient may bo 
wide (Kleppor #02)*
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F r0 s 01 & t ytuûy
Method of asoay of urinary pregaonedioi
The aaaay method iiood in the preoont invoetigation
la that of Kloppcr et al (1050)# All as a ays w^erc 
made o« 24 hr# urino collciefelona which vmro performed 
at weekly intervale*
Method of cipsay of tifJjmry oootriol
In the prooont invootigationo two methoda of assay 
v/ero il sod# For very onriy pregnancy the classical 
method of Brorm (1055) was used hut after 12 weeks of 
gestation the ehorter method of Kloppor A AMlson (19 02) 
was preferrod# In the latter method the first four 
steps of the Brown {1850) method# acid hydrolysis# 
extraction# solvent partition# and hot alkali treatment 
are used and the ocatrial content of the residue is 
dotormined by the Kohôr reaction as in the Brown method# 
Bccamoc in early pregnancy more than 5 m l # of urine has 
to he used in order to got enough eestriol for accurate 
0 p u c trophotometrio mensuroment suf f1cient impurlty 
remains in the eestriol fraction to produce an appreciable 
increase in the background colour# A further 
purification step is# therefore# necessary with early
56.
prognanoy urine. This is achieved by methylating 
tli0 oeatrloi fraction froui the chromatographic column 
and then recovering tUo S-methyi other by a second
chromatographi.o step «
Urinary ocstrlol was studied, in three groups of 
womeifi ( i) IMormally pregnant women (2 ) iVomon with no 
successfui pregnancy and at least two abortions none 
of v/hich had exceeded 24 weeks go station* The pregnancy 
studied ended successfully*• (3) Women who aborted in
the pr egn a n cy stu d i o cl.
Urinary pregnaaodiol excretion was also studied in 
groups t and 3 and the levels compared with those 
reported for normal pregnancy by Klopper & Billewicg (lOOS)* 
Urine collections from women in groups 2 and S wore 
always started before the gestation time at which any 
previous abortion had occurred* This io important# 
since as pointed out in Chapter 2 # abortion tends to 
occur at the same time In ouocessive pregnancies# and 
trends of excretion might be missed if collections are 
begun after this time# furthermore the individuals would 
then be selected toward continuation of the pregnancy.
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ResultsCii crv-K3: tc:." .era
P r e g n a noûi o1 exc r etlon
Tables 2 0# 26 â 27 show the mean excretion of 
pregnaBcdiol with standard deviation in the three groups 
from 5 * 16 weeks of pregnancy. There is no 
statistically signifieanfc difference between the three 
groups at similar stages of gestation. The moan of 
the " successful two previous abortion" group tends to 
be slightly higher at each stage than the normal group 
which was composed mainly of prijnigraviclae. This . 
suggested that they were behaving# as far as pregnaneclioi 
is concerned# like multiparous women. Kloppor and 
ilillewxcx (19 63) showed that primigravld women excreted 
significantly less pregnanoctiol than multigravldae 
during pregnancy and these findings support this 
obserV€ition* Shearman (19 69) did not give sufficient 
data in his paper but (Personal communication 1968) did 
say that other date, he had confirmed this view*
Spécial Gases
Two individual cases where pregiianodiol excretion 
had been measured in the luteal phase of the menstrual
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oy€ie before a pregnancy had occurred have alno been 
«tmUotU Figure 1 * in one woman the prognanecllol 
level rose te 14mg/24hr# at II week® of pregnancy# well 
within the normal range# It then dropped to 4mg/24lir# 
at Î0 weekfô# the normal non pregnant luteal level for 
this individual# Thereafter it rose steadily until 
term when the patient waa delivered of a normal child# 
At no time during the low level of pregnanedioi were 
any signs of abortion present#
The second subject had a rise in urinary 
pregnanediol level to I9mg/24hr# at 10 weeks# The 
lovol then fell to 2#5mg/24hr# at 25 weeks# the normal 
luteal level for this patient# Spontaneous abortion 
occurred shortly after# These serial results 
indicate that even this type of measuroment in 
individual women may give little indication of the 
outcome of the pregnancy#
Tables 28# 29 & 30 show the urinary oestriol 
excretion in the S groups from 5 - IS weeks of pregnancy# 
Again no aignificant difference in excretion is 
evident# Figure 2 shows that up until IS weeks some
womoit v4'io are going to abort show a remarkmbly normal 
aoGfcriol excrotlon# serial roacliiige in these women 
give little indication of impending abortion#
The gestation period studied in those siihjocts 
was hotwoan $ anû 16 weeks of pregnancy and little 
indication of impending abortion can he gained from 
these studio»* However# in later abortion» some 
information may he gained by the measurement of 
oostriol excretion in a similar way in which it lu 
used to give information in late pregnancy# Oestriol 
excretion in the urine in late pregnancy has given 
inf0 $uHaticm as to the well being of the foetus# After 
ZO vmolio the excretion of oeetriol in the maternal 
urino gives information about the growth of the baby# 
Goylc and Brown (1003) studied the excretion of 
OGstriol in 51 women who were delivered of hahias 
weighing under 3000g# after a gestational period of 
more than 3 7 weeks# In this series the oestriol 
Values wore normal until about IB weoks but thereafter 
the rise was two thirds of the normal level after 
30 weeks# oostriol excretion appears to correlate 
with the weight of the hahy# a finding also reported 
by Frandsen and Btakemmn (1060)#
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In a patient being studied as a casa of normal 
pregnancy# oeatriol emeretion remained lew for 3 month» 
before abortion finally occurred at 26 weeks (Fig* 3)# 
pasiSibly reflecting the decline in foetal vitality 
ami eventual foetal death# ■ Pregnanediol excretion 
dill not fall until shortly before the abortion and 
presumably remained at normal levels until placental 
death irrespective of the state of the foetus# Those 
findings therefore support the contention of Kloppor 
aiKl Oiilcwicfls (1063) that up to 20 weeks of pregnancy 
or 00 the urinary oestriol excretion represents 
oestrogen pTOdnctioii by the tropliohlast from maternal 
precursors and perhaps the ovary# while later in 
pregnancy the effects of the foetal production of 
precursor»# proviousiy discussed# become important#
It has bocir eiiggcsted that differences in horsaonal 
concentration between oestrogen ami progesterone 
influence myométrial contractility in the human 
(Bcngtsson I8G2)# This suggestion ia baaed on 
iavootigatians of the hormonal coîitrol of the rabbit 
myoïeetrium and Csapo (1901b) was able to produce in
G*,
aïiimal condition a resainïillng nUsaed alsortAon 
t m m m  of progi^0teronù iûJeotAoîiB at^tor romoval of the 
ovary and reparation of the placenta# Csapo ( IP G Ia) 
Bt%Bgont0 û that p r o g e s t e r o n e b y  effecting the membrane 
potential of the myométrial ceil might block the 
PMpagotion of contraction wavco through the uterus * 
Kuriyama and Csnpo {lOOO claimed that the myomotrial 
block MBS most pronounced in the immediate vicinity of 
the placenta9 supporting the view that the roatraining 
factor was-derived from the placenta# A second hormonal 
factor concerned in myométrial activity may be oestrogen. 
Corner aiul Csapo ( *DGS) in a study of the contractile 
Byutern of uterine muscle found that the concentration of 
the contractile protein actomysing could be increased by 
oestrogen#
K1 o p3>er an<i B111 owIcs (19 Gg ) a t ud i ecl oe s tr Io 1 
excretion during pregnancy and suggested that this 
particular oestrogen might be concerned in the onset 
of labour#
If# therefore# one measures the excretion of a 
progesterone metabolite (prognanodiol) and ocstriol 
in women who abort# the ratio of these hormones present 
at the time of abortion may be obtained.
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Fow vmrkor^s have Iti fact measurac! the pragnanodioi/ 
ôcifïtrioi ratio.# Kaiser (tBûù) considered this aspect 
but made monthly measurements in only one woman#
Eioppor üUû îUllewicn (?063| macie some observations 
on this sulijeet (Pig# 4)# they fourni that in early 
pregnancy about 100 times as much pragnanodiol as 
0 es trio 1 is being excreted # l)y 30 weaüîB the ratio 
has fallen to about S?î# They u I b q ehserved that 
subsequent to 30 weeks the ratio continued to fall 
althoughI more slowly# and by term the amounts of the 
W o  motoholitoe were approximately equal#
frognanodiol/oeatriol ratio in the nreaent study#**###*## VI Ik Ww#'»jw "I «!#.«# wti'U nr
Table© 31# 32 and 33 ©how the ratio of excrotion 
of liriaary prognanedioi and ooetriol in the three groiipg# 
Thera are great variations within the groups and this 
may he clue to the small niimhm's at some weeks of 
gestation# However# there is no significant 
difference between the groups#
Tlio r0snit.s shown here suggest that there is no 
significant difference in urinary excretion of oostriol 
and pregnanedioi An abortion and An normal pregnancy#
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There are many reports of urinary pregnanedioi 
levels An tlu'oatenod and habitual abortion and reBult» 
vary greatly* Borne reports ouggeot that a decreasing 
or constantly low excretion is followed by abortion 
(borglin IDUdi Rawlings a Krieger 105Oj and others). 
Other investigators have found pregntmedlol 
doterminationo of little progsîostic value (Russell et al 
19^7). Measurement of urinary pregnanediol in case© 
of threatened and recurrent abortion has sometime© heon 
used as a criteria for-'-'^progostin therapy. In some
reports therapy has been based on the results of single 
ae 1-3ay8 (Kupperman et al iGGOj Morgan et al I960).
It ie evident from the series reported here that this 
ia not juatifiahla.
It ia interesting that great variations occur in 
pregnanedioi excretion in the same patient. This is 
very evident in the case shown in Fig* f# where the
pregnaaodiol excretion fell to luteal levels at 1? weeks
and then rose normally to term without any clinical 
evidence of abnormality in the pregnancy. It could he
suggested that the fall was duo to the failing corpus
0 4  #
lut m m *  However# it lias been shown hy ûicsgfaiuay
and Bereii (laoi) that the ovarian contribution to the 
excretion of both oestrogen and pregnanocUoi at this 
©tag# of pregnancy Ib very email if indeed there is 
any at all* In pregnancy variahie amounts of 
administered progesterone are converted to pregnanedioi 
(see Chapter 4) and# furthermore# prognanodioi has 
been isolated from the faeces during pregnancy as 
mentioned already (ICIopper and Macnaughton 1059)*
It ii clear# therefore# that changea in pregnanediol 
excretion may he due to alterations in mmtaholism and 
may not entirely reflect progesterone production* It 
l@ plain from the results that pregnanediol excretion 
gives little indication of the prognosis,
file same is true of oestrlol measurements up to 
tê weeks of pregnancy* Thereafter when the production 
of foetal precursor hecomes evident oestrlol results may 
he more meaningful# as In the case mentioned when 
oestrlel output was depressed for # months before 
abortion occurred at ZM weeks, The findings are In 
agreement with those of Kloppor and hlllcwicz (lOOS)*
A Similar picture is reported hy Coyle and Brown (19631
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whea îBeasurcîmcmt of oostriol excretian proved of 
great value Am aweseimg ttm viability of the footiio 
im üaaea with compile at ions mtcli m  pre-eelampsla and 
poor foetal growth syndrome# ll^îmol and r/lartln (t004) 
have also found that ttw ooetrogom osoretiam. lu easea 
of threatomod abortion oontlmiimg to term wao not 
oignlfieamtly different from normal hut that la eaaea 
of Inevitable 'ahortlom the urinary exeroticîn of 
oastrtKliol I7p and ooatrono was mlgniflemntly lower 
thmi In the normal groupa probably duo to the troplio- 
biastie and foetal production being eat off by this tima.
The ratio of prognunodiol to oostrlol in normal 
pregnancy has been eonoiderod by Kaiser (I960) and 
Klopper and billmvleg ($06$)# It IG clear from the 
roDuits of this study that there is no significant 
change in this ratio before abortion ocours# flere It 
s h o u M  also be remembered that both oostriol and 
prcgnauodloi are the end results of a series of 
metabolic prooeesos and may not reflect events occurring 
at the cellular level# Short and Meoro (IBS#) m û  
rkilker (t065) found no change in blood progoatorone 
levels at the onset of labour and £3ton and Short (3ÛC0) 
could find no constant relationship between blood
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pragestorone ievata ona the outcome of throatonod 
abortion* Fig* ti #ho%m tho relationship of blood
ppogeatcroria lev ole in pregnancy (Bton m û  Short 1060) 
mid urinary excrotioa of progaaooctiol (Eioppar m û  
Mli e w i o g  liOS# asid Shearman ÎOSO)*
A # Urinary excretion of ûestrogpii and Pragoaoodlol in
ll5*datidifor2ii Mole
It is well ostabliohed that the urino of patienta 
with liydntidiforii mol# contain© high concentratione of 
chorionic gonadotrophin (Hamburger 1043) imt there aro 
few reports on the excretion of other hormones * 
rigeam! and Bnrthiaiiit (îOiî) found that seme patient© 
with hydatidiforra mole euerotocl increased amounts of 
prognancclioi# some normal and some diminished amounts* 
:^ îûiidor and von Umretovmann ( reported that mole
tisaiio had almost the same concentration of progesterone 
ao normal placental tissue. Payne (U)4i) fount! a 
normal excretion of ocstrogens in two casco of 
hydmtidiform mole and Uingimis and lilngloia ( 1049) 
reported a similar finding An 10 ecieco* la both these 
investigations a biological assay method was used#
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In five 00009# however# Smith m û  Smith ( 1035) fourni 
eiior0 fcioft of oestrogen which correopomicd to aon^ 
pregaoiit levels# Brb et al ( 30G1) ropertocl on two 
cases of hyclatidlform mole a n d found that one patient 
excreted normal amounts of the three classical 
eoBtrogena# east rone# o estradiol and ooetriol I m t lev; 
amouuto of pregnanedioJ, v/liorea$ the other cMcretecI 
sraall amouûtû of oestrogen *■ the lower l i m i t  of the 
normal rango « hut normal amounts of prognanecUol#
Framloen and Stahomaii (10 04) have reviowocl eomo 
of the information eoncorning tho excretion of theoc
hormonea In liyûiitlûifùm mole -and have -ûmcvibQû their 
fiiiclirigo in 10 caeee. They conciiidod that g aa far as 
prognanodiol excretion was eoncerned only one out of 
five caoea had an excretion level similar to that 
found in normal pregnancy# whoroao ail the others had 
n lower excretion level- like that found In tho non*" 
pregnant subject*
far as oeatrlol excretion v/as concerned they 
found that this wae# In general# much lower than in 
normal pregnancy of the game gestation period* In 
addition the ratio of excretion of oesfcrlol to ooatradlol
mul oüstrona corresponded to that found in the non- 
pregnant woman* Theee workers concluded that oestrogen 
metabolism In cases of hydatldlform mole resembled that 
found In the non-pregnant woman *
It waa thought that# since there was some confusion 
In the literature about the excretion of oestrogen» and 
pregnanedlol In cases of hydatldiforra mole further 
Information was desirable as this would help to 
elucidate the hormone picture In early pregnancy there 
being no foetal component In cases of hydatAdiform mole*
A small number of suitable cases became available 
and wore studied from this aspect*
Methods of Assay of the Hormones
In eases I and 2 ocatrone# oestradloi and oestrlol 
were moaaurod by the method of Brown ( îOB'g) anti In eases 
$i 4 end 5 oostrlol was measurod by the method of 
Bpom% ami Cay le {#003) #
Prognonedlol was measured by the method of 
Kloppar ofe ul (IS5G)*
Gaee #
flifâ patient was a priraigraviila aged 21# who was 
admitted with vaginal bleeding at the 10th week of 
pregnancy♦ fhe îlogberi test was positive in a 
dilution of U ÏOÛ but negative in $?200* The uterus 
was enlarged to the expeotod at 14 weeks of
goetation an# continued to grow more rapidly than 
normal# Intermittent hlcacîiiitg continued and a mole 
was imsaed at 17 wooks*
Game 2m
The patient was a primigravida aged 24 years# who 
was admitted at the I1th week of pregnancy with vaginal 
bleeding# The utoruu wao of normal also for the 
gestation period# The iloghen teat wan positive in a 
dilution of I g 100 and negative 1:200# Intermittent, 
bleeding continued and a mole was pnaood at IP weeks# 
Three weeks later the patient was ro-admitted to 
hospital with severe vaginal bleeding# flie uterus was 
hiiIJcy and soft and a blue vascular nodule was present 
ill the lower vagina# Froaen sections of cwettings 
and Qf the nodule suggested chorio-carcinoina so
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hyotoroGtomy cmd excision ef ' nadiiio were pur formed.
At oliquation two thuqa iutoin qyoto vioro found 
rsoaouring ? x 5 n 4cm® and B x 7 u lorn, roppectivcly* 
Histology of tho utorus and vaginal module uuggastcd 
that tlio condition was ohorlo-adonomn doo.truoiie am! 
not Churio^onrcAn m m * Follow up over the next tea 
yaaro ohowod no evidence of recurranee and the titre 
of gonadotrophins in the nrino romainod noraai,
SSiiLl
TiiQ patient ivaa aged 2 6# para 2 # admitted at 
l‘B weekG gestation with yaginai bleeding, flio uterine
also vaiB -normal for the gestation period. The pregnancy
continued with intermittent bleeding until tlio 10th
when the blood proaoure rose to 200/ $20mmUg and 
the urine contained 12g/l of albumen, Spontanoouo 
delivery of a hydatldlform mole followed the aente rise 
in blood proaeuro. The patient has since had a
normal prognanoy.
;aeo
The patient was a prlmigravida aged %B years# who 
wao admitted at SO woolts of pregnancy with vaginal 
b l m é i n g *  The utoruB waa small for thcî gestation period#
It
TilO llogbep tfôsfc wao weakly piisitivo Is 10 dilution# 
later mit tant bleed in# eontlnuW and a mole was paesocl 
at 20 waeke,
0a©0.6
flm patient waa aged 26# para 2$ and was admitted 
with intermittent vaginal bleeding at It weeks gestation, 
The uterine sisse waa normal for the gestation period# 
flte Hogbon test was positive Is 10 dilution hot negative 
Is 100 dilution# intermittent Weeding continued and
a mole was paeoed at 16 weeke#
Rerolto
fahlo 34 B h m m  the urinary excretion of hormone© 
in the B eaaea# Fregnanecliol excretion and ocetriol
excretion were measured in all oaooo and the three 
^olnooioal^ oestrogono and prognanodio1 in two oubjocto#
PfQgnangdioi
In Q t m m  î and @ the levels are higher than in 
normal pregnancy wlieroaB in Cases 2# 4 and B the levels 
are much lower than normal and indeed approximate more 
to thaoo found in the non-pregnant state#
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GrxitrlOl
0(11S»
Oaeo I* The levels of oeatrlol exorotlon t^emalned 
normal until N  lyooka thereafter flattening out 
In a manner found In Intra uterine death already 
mentioned*
Gaae 3$ Only a single reading at #  weeke was 
available* This was lower than normal but 
consldei'ably higher than those fmmd In Caeos 2 
and 4 %vWro rooult# wore available at 19 %veoka# 
Cnees 2# 4 and 6* The levels of oeatrlol excretion 
in these oubjecto wore much below the nojrmal 
for the gestation period and wore almllar to the 
levels reported by Frandocn and stakemen ($004) 
fo%* hydatidiform mole#
r,Bjslïfc^.=!k*T^-s*fe‘»^SAa!^-s;'ÿr'4.5si!ss4tt^
The levels of these {eWroldo tended to follow 
those of oeetrlol# being high la Caae I and loiv in 
Case 2$ The oeetrloliooatrone plus oestradiol ratio
Varied from i to 4,7*
A0 has been mentioned before it aoema almost 
eartain timt the plaoenta produooa progesterone and
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In Case I Ml thin ©orics# the lovelB of oostriol 
romainod high until the letli week of pregnancy# while 
tUoBii of pguignanedioX were above those of normal 
oubjeoto nt the same goatation period* In this 
subject at iaaet until the 16th week# the ooBtrogen 
production v/ao v/ithin normal limits in spite of the 
absence of a foetus*
It 0ooriK> posalble> therefore to have normal 
oestrogen production in the first B month0 of pregnancy 
without - a foe to** placent ai circulation*
The oestrogen level might be duo to inoroaocd 
production by the ovaries# which may he cxcosaivcly 
stimulated by the largo amounts of gonadotrophin 
present# This seems doubtful# however# oinco from the 
data in fable f of the paper of Frondeon & Stakeman (1904) 
fable 35) the lovol of gonadotrophin was lowest in the 
patient ivith the higEieat level of oostriol# In the 
present oaoeo there vms no correlation between the 
level of gonadotrophin# as measured by the flogbon tost 
end the hormone excretion# or the presence of theca
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lutoiii oyats m û  the oxcrstion love,I* The hormone 
may therefore# either he produe od l>y the ovary or hy 
the trophoblaot# pooolhly hÿ a different motaholie 
pathway from that foimd in normal pregnancy# and 
further vmrk to try to elaoldato this problem la 
roported in Chapter 0.
275.
CHAPTER 4.
The Conversion of Progesterone to Pregnanediol
IB chapter 3 .i, when the origin of pregnaneclioi was 
discussed the relationship of the amount of progesterone 
represented by urinary pregnanediol was mentioned#
Almost invariably estimates of urinary metabolites aro 
made to obtain inforaiation about the production of the 
original hormone. For this purpose it is useful to 
know the ratio between active hormone and inert 
metabolite and it is essential that some fairly 
constant relationship should exist between the two to 
make results meaningful# Hytton & Loitch (19 64) 
rightly remark in their book ®The Physiology of Human 
Pregnancy^ that *Mt is curious that so much research 
has been expended on polishing the technique for 
estimating pregnanedloi ami so little on discovering 
how faithfully it is likely to x^epresent its parent 
hormone’* # It was with this admonition in viev/ and 
also because of the rather vax'ied results reported in 
chapter 2 that it was decided to investigate further 
the relationship of progesterone to urinary 
pregnanediol.
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Percentage recovery of injected progesterone as 
urinary pregnanediol
This figure has varied from report to report.
X
The foiiowing are some figures from the literature#
7.9^ Qiiiiligan and Rothchild ( 1957) ; 9- 16)& Sommerville 
and Marri an (I960); 20^ 6 Klopper and Michie ( 1956) ;
approx. 20?S Guterman ( 1963); 20-40J4 Davis and Plotz
(1957) and 30-35^ Davis and Fugo (1947), Some 
workers have also reported that the percentage recovery 
of administered progesterone as urinary pregnanediol 
is higher in pregnancy than in the non-pregnant state 
(Venning and Browne (1940); Sommerville and Marrian 
(1950); Guterman (1953).
In contrast Pearlman (1957) using tritiated 
progesterone found that the conversion of administrated 
progesterone to pregnanediol was lower in the pregnant 
suhject (6-15/0 than in the oophorectomised/ 
hysterectomised woman (14-27$)# This latter finding 
seems more logical ,since some of the administered 
progesterone could be taken by the foetus and/or the 
mother whereas in the non-pregnant woman it would 
overload the system giving rise to increased conversion
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and excretion of pregnanediol# It also seems true 
that the exogenous progesterone can bo converted to 
pregnanediol in the absence of a uterus and/ef ovaries^
IÏ11X ton (1040 ) and Gut or man ( 10 53 ) •
Present Study
In view of the varying résulté obtained and 
relative lack of information on the conversion of 
progesterone to pregnanediol it v/as decided to 
investigate this problem further using tritiated 
progesterone to study any difference in the conversion 
betv/een normal, and abnormal pregnancy and to determine 
whether the conversion values v/ere related to 
abnormalities of pregnancy# especiaily early pregnancy* 
Outorman {IS53) had suggested that there was a higher 
conversion of progesterone to pregnanediol when a 
Viable foetus was present•
Metabolism of progesterone
Pregnanediol is considered to be the principal 
urinary metabolite of progesterone# F/eist et al (1958) 
and ih no report has more than 40>^ S (average 2i>%) of 
administered progesterone been converted to pregnanediol. 
When progestérone was injected Davis et al (1956)
recovered 28.54;;% from the faeces in the next 10 days# 
t^egjligable amounts are secreted via the skixi (Davis 
and Plot 15 1057) and although no 0^ could he detected 
following administration of 4-C^'^ progesterone Og was 
found in expired air after administration of 2 
progesterone ( 18-19;^ In 31 hr.) Davis and Plots {1958), 
This final report illustrates that the side chain can 
he broken off in mctahoiism with the possible formation 
of androgens o*g* androsteuedione# andx^osterone and/or 
a tiocho1ano ion c•
It has been reported that a large amount of 
progestox-’one is stored in maternal fat (Kaufman and 
Zander# 1950) and Plotz and Davis (1957), The latter 
workers showed that after 12# 24 and 48 hr# 17# 7# 33 #7 
and 1D#6A' respectively of injected progesterone was 
found in maternal fat either as progesterone or its 
motabolites#
Until radioactive px^oge star one could be administered 
in the form of tritiated progesterone other urlnax'y 
metabolites of progesterone could be detected only with 
difficulty# The use of labelled px"ogestex^one in humans 
has shown that this hormone can also be metabolised to
7D.
Compoimds which are more polar than pregnanediol.
Chang 0t al (1960) found that 2% of the administered 
dose appeared in the polar fraction and Contractor and 
Pearlman (1D60) found 0.6 - 2% of the administered dose 
to appear in the ketonic polar fraction. Since these 
latter workers used progesterone labelled with tritium 
at C-10 and also hydrolysed the urine with acid it is 
likely that many of the polar compounds were destroyed 
and the figure they quote is therefore much smaller than 
the true conversion. Greater conversions have# in fact# 
bean reported by Darkness and Potherby (1063) who 
found about 6^ of the administered dose in the polar 
fraction and by Romanoff at al (1963) who found a 
value of 6 - 7fi. The results of Darkness and Fotherby 
showed the ketonic fraction to contain a greater 
proportion of these polar metabolites than the non- 
ketonic fraction.
It seems likely that a large proportion of the 
polar fraction is composed of metabolites with an oxygen 
function at position 6# Kamyab and Fotherby# (1963)# and 
James and Fotherby (1965) have shown that the 
administration of progesterone is also associated with 
an increased excretion of these 6-oxygenatod metabolites.
8 0 .
A number of compounds with a hydroxyl group at 
position 16 have also been isolated from urine* These 
compounds arise partly from l6a-»hydroxyprogesteroao#
This compound has been isolated from corpora lutea 
and placental blood after normal delivery (Zander et al 
1862)# and also from the peripheral metabolism of 
progesterone or its metabolites (A^'otharby 1864) *
Therefore# although conversion of progesterone to 
a number of other metabolites occurs in the human and 
many of these metabolites can be isolated from human 
urine following administration of labelled progesterone# 
pregnanediol is the most characteristic metabolite and 
has been most commonly used as an index of progesterone 
production. The radioactivity recovered as urinary 
pregnanediol following intravenous injection of 
tritiated progesterone gives a measure of the conversion 
rate of progesterone to pregnanediol*
The method used for the estimation of pregnanediol. 
v/as that of Klopper et al (1866). It is considered 
specific for 6j3-pregnanc-3a-20a-diol since the 
final purified diacotato is only slightly less pure
I.
U u m  the diacetata of the pure compound (Klopper et ai 
I055| Coyle et al (1956))* The method Involves acid 
hydrolysis# toluene extraction# a permanganate 
oxidation step to remove the--decomposition products of 
pregnanediol following acid hydrolysis# chromatography 
on a n 'alumina column to isolate the free pregnanediol# 
acétylation and further chromatography to isolate 
pregnanediol diacetate# The final assay is by colour 
development with sulphuric acid« No correction was 
made for extraction loss # all studies were comparative 
am! losses occurring during the procedure were known to 
be constant within the overall error of the method.
Measurement of the radioactivity present In the urinary 
pregnanediol following the intravenous injection of 
progesterone
The radioactivity contained in the pregnanediol 
diacetate produced was measured in a Nuclear Enterprises 
single channel liquid scintillation counter. The 
efficiency recorded when tritium was measured was 22*5;à# 
The radioactivity was measured in counting vials of 
Î 8 m 1# c a p ac i ty #
The scintillation fluid used consisted of:-
^2.ô
4g, 2#J DApheByloxaaoXfô (PFO) txnû 0,05g# p-bls[2-(5- 
phenyioxaxa.lyi) 3 benzene (POA^OP) .litre of toluene
(Seintillation grade)#
The components of the scintillâtion fluid were all 
pur chased f rom Nueleav En t er prises.
To remove any errors in radioactivity measurement 
cUve to the background urinary material extracted g a 
sample of urine obtained prior to the radioactive 
injection was also extracted. Since the dally 
percentage recovery of injected progesterone as 
pregnanediol falls off marlcedly after the first two days # 
larger volumes (ISO mi.) from the 3rd* # 4th and 5 th days 
had to be extracted to give sufficient counts for 
accurate measurement#
pTiplleate analyses were performed in all cases and 
cluplicato samples were also extracted for direct 
measurement of the pregnanediol present#
The overall findings are expressed as results under 
the following headings -
1), The absolute amount of pregnanediol excreted each 
day in mg/24 hr. pregnanediol diacetate*
2). The amount of radioactivity recovered each day and 
hence the percentage of tritiated pi^ogesteroiic 
injected ivhich ia converted to pregnanediol and 
excreted on each of the 6 days*
The amount of radioactivity loft in the syringes 
and ampoule» after injection was measured in a number of 
eases# The average amount remaining in these was 
1 #19*10 (sn t 0.20) in Î4 cases# This means that an 
average amount of 98#8lpc was injected# In view of 
the very small error involved results were calculated 
on a basis of 1O0?4 injection of the progesterone#
R esults
The patients studied ?/ere separated into fouri main 
groups: non-pregnant# early pregnancyt late pregnancy
and women with abnormal pregnancies# One hundred 
microeurioa of tritiated progesterone dissolved in 
ethanol were given by intravenous injection into the 
antaciihital vein and urine collected in 24 hour periods 
for 6 days after the injection#
The daily percentages recovered as pregnanediol on
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the first 5 days are tabulated in Tables 36# 37# 30 & 39#
It is clear that the majority of the radio- 
active pregnanediol was recovered in the first 24 hour 
urine specimen after injection of the labcliod steroid* 
The excretion of radioactivity fell to very low levels 
by Day 5# Tabic 3 6  Illustrâtes the recoveries in the 
non-pregnant subject. In Casa No, 3, it should he 
pointed out that the probable reason for high recovery 
on Bay 2 was due to post operative renal retention.
On Day urine volume3 creatinine excretion^ and 
pregnanediol excretion were all sub-normal• The 
percentage recovered as pregnanediol in the group of 
non-pregnant subjects varied from 5*69 - 14,2 1% - a 
fairly wide scatter*
Table 3 7  illustrates recoveries for subjects in 
early pregn ancy *
Case 11 had tritiated progesterone injected into the 
Uterine muscle Just before hystcrectomy and the first 
48 hour urine sample was pooled* In the 11 cases of 
apparently normal early pregnancy studied it can be seen 
from the table that the total percent recovered as 
urinary pregnanediol varied from 6*8 1 - 15*14, There
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appeared to be no difference from the 7tb to 19tb week# 
the amount recovered depending on the Individual# In 
Gaee 11 where an Intrauterine Injection was performed 
the percentage recovered was 10.79 and fell within the 
range repoa^ted after Intra venoue Injection#
Table 38 ebows the conversion in the late pregnancy 
aubjecte (all three are in the last 2 iveeks of pregnancy)# 
The total percentage recovered in these women varied 
from 6*74 - 16#36 and again it appeared thtit any 
difference seemed to depend on the Individual rather 
than on the stage of geatatlon#
Table 39 includes a number of clinically abnormal 
Casas showing their conversion over the five day period#
In this group the percentage recovered as m'inary 
pregnanediol ranged from 1*42 to 9*90 (Case 22 had only 
a three day recovery period but assuming that she Aiad a 
similar fall in percentage recovex^y as is present in all 
other cases the total recovery should hardly be 
influenced)# Although there is a wide range in the 
total percentage activity recovered as pregnanediol the 
average In the abnormal cases appeared lower#
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Table 40 iXiustrate© the variation between the
four groi,ipo# Testing for significance by the test
there was no significant difference between the non- 
pregnant^ early pregnant and the late pregnant subjects# 
Howeverp there v/as a significant difference between 
abnormal pregnancy and the other three groups and it 
seems likely that there may be some altered metabolism 
of progesterone to urinary pregnanediol In these 
abnormal cases, Further work on this oubJect will be 
described in chapter 6,_
Specif i c A c fc ivi ty o f t h e p r egn a n ed J. o 1 i so 1 a ted
The specific activity of the pregnanediol diacetate
isolated from the urine was calculated for each of
B urines# The pregnanediol excretion in jug/24 hr# was
determined as pregnanediol dlacetate#
( radloactivity in pregnanediol diacetate )
( Specific Activity muc/24hr# % 1000
mg, pregnanediol diacetate/24hr# )
Table 4| illustrates the daily specific activity of 
the isolated pregnanediol diacetate. The results may be 
separated into two main groups. The first group 
contains all the patients whose specific activity of
o
7 #
pregnanediol diacetate is above 460mpc/mg on the first 
day and above ïüOmpc/rng on the second day* The second 
group contains the remainder although there is possibly 
a small third groi%p present which does not fit either 
category *
The n o p r e g n a n t  cases all fell into the first 
group together with 5 out of 11 of the early pregnant 
cases » No late pregnane 3^ or abnormal cases were in 
this group. In the second groupp all but one of the 
late pregnancy cases were présente The third group 
contained a mixture of early pregnancy and abnormal 
cases•
Since the radioactivity^ excreted in the urine as 
Pregrianedid xvab aImost constant^ i• e* there xvcre no 
significant differences in the percentage recovery 
between the early g late and non^pregnant subjectsÿ 
when the pregnanediol was low - the non-pregnant and 
early^ pregnant women - the specific activity was high. 
Conversely, in late pregnancy, when there was an increase 
in the pregnanediol excretion the specific activity was 
low*
These results do not suggest that specific activity
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per se gave any particularly useful additional 
information about the various typos of pregnancy 
studied#
conversionaxcret
woman
The results are shown in Table 42*
The percentage conversion pregnanediol fell 
within the usual range for a non-pregnant subject hut 
the specific activity was extremely high due to the very 
low absolute amount of pregnanediol excreted dally.
Excretion hy same patienta non**pregnant and pregnantw *** 1IMwiwi'u I u * m iMW#Mumiwwiwiiowmmniwtwioei^ wM**wmn**'.itwii,
Two patients were studied in these two states to 
determine whether pregnancy changed the conversion in 
the same individual*
Cases 5 and 21 were the same patient in the non­
pregnant and then the pregnant state - before abortion* 
Similarly Case 4 and Case 8 were the same patient in the 
non-#pregnant and then the pregnant state. Direct 
comparison of these results is shown in Table 43*
When both women becmma progaaat the 
radio0 Ct ivlty rcoovox'W a$ pregnanediol dropped olightly 
and ÿ sli'KTü the at solute amount of progaoaedloJl rose 
with pregnancyÿ In both ooocs the apoclflc activity 
Uocroaood*
DiùcusAion*S:^iV•lXirJ’■s‘:MllJ^*StS*»^IS^^,^!SiH^
The average amount of radioactivity recoveroU as 
urinary prcgnanodioi over l> days after iotrnvonouo 
injection of tritinted progootcrono in nomoi non** 
pregnant and pregnant subjects worn lOÿl with a range of 
6*221% one #0*68^# This roauit compared favourably 
with previous reports Quiiiigan & Rothahiid (#057)$ 
Bo^worviiie & Marrinn (#050) nnd Gutormcn ( $983) aitho%;gh 
not 06 high m  Davis A Plotz (105?)& Noweverp contrary 
to Ve*%ning and Browne ( $040) and Bommorvilio and 
Wnrricn ( 1050) ivho found highcr levelo of rocovery in 
progooncy than in non*pregnancy# and to roarimon ((067)$ 
who# oonvoroeiy» found higher levela of recovery In non- 
pregnant vfomen# this work cuggoato that there la no 
difference in the percentage recovery between the 
pregnant# (early or late) and the non*prognant women * 
Kloppcr and Miehic (1800) also found no difference in
oo*
recovery# ÎIcmce It would appear that the proseoco 
of a foetus does not make any difference to the 
percentage of progesterone that is converted to 
pregnanediol# In one case# in the present study# 
in which abortion occurred the percentage recovered 
as pregnanediol was low# This result is in
accordance with the view of Outerman (1053) who 
euggOBtod that the percentage recovered as pregeanedioi 
was higher whon a viable foetus was present* It is 
clear that this matter io not finally resolved and 
further work is required to clarify this point# In 
contrast to this# patients with abnormal pregnancies# 
for example hydatidiform mole and pre-eelamptic toxaemia# 
toncl to have a lower percentage conversion (average 5#32#) # 
The production of progesterone in those cases is lower 
than normal since the absolute urinary pregnanediol 
levels tend to he low also* In the hysterectomised 
patient# (Table 42)# the percentage recovered as 
pregnusiodioi was within the normal range and this 
confirmed previous reports that the uterus and/or 
ovaries were not necessarily required for the normal 
conversion of progesterone to pregnanediol# Romanoff 
(1002) in fact# found t4% of administered progesterone
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Converted to urinary pregnanediol in men.
Although a viable foetus was delivered in Case 30# 
an extremely^ low conversion to urinary pregnanediol 
(0#4%^) p and absolute urinary pregnanediol exçretiori 
(2•5mg/24hr0) were found# neither apparently in­
consistent with a successful pregnancy* It seems 
likely that the metabolism or excretion in this case 
must be different, The total urinary radioactivity 
In this case was only 1 @ on dàÿ 1 suggesting - 
(I) alternative excretion route (2) some alteration 
in metabolism or (5) increased maternal fat storage or 
of ^bound ^ progesterone « (Table 44)*
fhe first suggestion is quite possible and is 
supported by the work of Klopper and â^lacruiughton (î95i>) 
who isolated pregnanediol from the faeces in late 
pregnancy. This pregnanediol was in the free form ami 
these workers suggested that the alimentary excretion 
of pregnanediol might depend on hydrolysis of its 
Conjugate in the gut, The^ '- also suggested that the 
possible alimentary' lose of a variable proportion of the 
pregnanediol production of the body might explain the 
considerable variation in urinary output pregnanediol
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as in the case cited.
An alteration in metabolism may be found in liver 
disease when disappearance of progesterone from blood 
plasma takes much longer (Patrini 1964)# probably duo 
to interference with the conjugation reaction-of 
pregnanediol (Rogers 1956)# Since the urinary 
pregnanediol excretion was low# the formation of 
progesterone was probably low and hence the increased 
requirement for exogenous progesterone which may bo 
^hotmd® to protein for transport and readily available# 
Hooker & Forbes .(1949)# or stored in the fat# Kaufman 
& Zander ( 1956) and Plotss and Davis (I9S7)#
The first 24 hour urine specimen after the intra­
venous injection of progesterone contained most of the 
labelled pregnanediol but over the next 4 days 
measurable amounts were still preao.nt. These findings 
are similar to those of RothehiId (l§53)# Harknees & 
Fotherby (1063)# Davie & flotss ( 1068) who showed that 
after a sharp rise there was a levelling off in the 
cumulative pregnanediol recovered 48 hr# after intra­
venous injection# Van do Wiolc et al (I960) reported 
that most of the pregnanediol was excreted in the first
9@.
!2 houTB v/lth some throughout the next 36 hr, and 
Quiliigan & Rothchild (19 5?) found that the majority 
v/as excrctofi as early as 4 - 12 hr, showing a very 
rapid metabolism to pregnanediol glucosicluronate*
Sommerville & Marrian (1960) detected a ’priming 
effect^ i.e. a stepwise rise in excretion of pregnanediol 
following administration of progesterone# which 
required the presence of a uterus* However# the 
results of Roth child { 195*3) gave no indication of this 
priming effect in the post menopausal female and this 
was later confis’med by Marri an et al (19 54) and Klopper 
& Michie (19 56). In the present study only the first 
5 days urine were collected and therefore this effect 
was not studied.
The results discussed in this chapter are generally 
rather inconclusive and a much larger series of eases 
would be required to obtain more concrete results.
The change in conversion of most interest is perhaps 
that obtained in hydatidiform mole. It was decided to 
examine this situation further and the results of this 
Investigation are reported in Chapter 0.
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Progesterone metabolism in the human previable foetus
When the metabolic pathways to and origins o.f 
pregnanediol were being discussed earlier in this thesis 
allusion was made to the foetal metabolism of 
progesterone# and foetal production of pregnanediol as 
a possible factor in altering pregnanediol excretion 
in the mother# This chapter describes work undertaken 
to ascertain the role of the foetus in progesterone 
metabolism and the foetal production of pregnanediol#
Introduction
There is good ovidenae that the foetus receives
'
progesterone from the placenta and metabolises this 
hormone# it had formerly been thought that the foetus 
itself was a source of progesterone wh en Forbes (1956) 
found that the level of the hormone in the umbilical 
artery was higher than in the umbilical vein. however# 
the method used (Hooker and Forbes 1947) was non­
specific and it was later shown that 20a-dihydro- 
progesterone (%Oa-hydroxypr0gn-4-en-3-one) had a higher 
potency in this test than progesterone (Zander et al 1958)#
95
Ruimebaum and Zander (1962) showed that the .level of 
progesterone in the nmhilioal arteries was conoiderahiy 
.lower than that in the umbilical vein # whereas the 
concentrations of 17a-hydroxyprogestorone# 20a and 
20p-dihydroproge6terono were higher in the arteries.
This v/as confirmed by Oroig et al (1962) who showed 
that the rati^ of progesterone in the arterial to that 
in the venous mmbilical vessels waa 1$1,8 and this 
finding was substantiated by Van dor Molen (1963) and 
ilarbet et al (19 64),
■ In view of the differences in progesterone levels 
In the umbilical vessels (see Fig, G) it seemed there­
fore likely that the foetus metabolized some of the 
progesterone it received from the placental circulation,
Solomon at al (1965) perfused foetuses of gest­
ational age 1 7 - 2 1  weeks with p r o g e s t e r o n e - 4 - ^ a n d  
isolated pregnanediol from the liver. This compound 
contained approximately 25/-S of the radioactivity 
perfused into the foetus. It was concluded from this 
and later work# by the same group (Bird et al 1965)# 
showing the pregnanediol was in the form of the sulphate 
as well as the glucosiduronate# that the function of
9 8 ,
the foetal liver was to produce reduced metabolites 
while the adrenal gland of the foetus at mid term 
utilized circulating progesterone for the production 
of corticosteroids.
Present Study
Materials and Methods
Several experiments were performed. The results 
of two# indicating the short and long term metabolism 
of progesterone are described,
O *  A foetus of 18 weeks gestational ago was obtained 
at thorapautic termination of pregnancy, A 
formalin soaked wad of cotton wool was placed over 
the urnbilical cord to prevent spasm of the vessels 
during cannulation, Progoatarone (2pc)
dissolved in two drops of alcohol and 1ml, of 0.9JI 
Sodium Chloride solution was injected through the 
umhilical vein. The heart stopped 14 minutes 
after the injection, The foetus was dissected at 
once# the organs removed# weighed and stored at 
-20^ until extracted.
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A foetus of 18 v/eeka gestational age was obtained 
at therapeutic abortion as in experiment 1*
Group Op ilh positive blood diluted 3s I (v/v) with 
dextrose in Ringer solution and oxygenated by 
bubbling oxygen through it# was used to perfuse 
the foetus by a modification of the method of 
Westin et al (1958). The composition of the 
perfusion fluid (pH 6.6) wasi glucose# 400mg/ 
100ml| Oxygen saturation; Cl GOm-eqiiiv/l • 
and COg content# 10.6m-equiv/i# After 
cannulation of the umbilical vesse3,s the foetus 
was immersed in B% dextrose in Ringer solution 
in a perfusion chamber completely filled with 
solution. In this way preasure changea due 
to increaa# or decrease in blood volume could be 
detected on a manometer. The blood dripped into 
the umbilical vein at a rate of 5 - 20 drops/min. 
Progesterone ( lOpc) vms injected and the 
arterial outflow collected for 3 x 16 mln, periods. 
The blood was centrifuged and stored as in 
experiment I* The accompanying diagram^ Fig# 7# 
illustrates the appearance of the apparatus used 
in the perfusions.
1
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The identification of radioactive metabolites and 
extraction procedures used have already toeen pishiiehed 
'■(Greig' and Macnaughton 1967) and will not ho described 
hero in detail* A flow sheet is appended# Fig# 8 
which shows the outline of the procodures.uscd*
asauife
ati±:i!£l,f:.go&gaiigy,a»«.
After 14 min# 40% of the radioactivity was present 
in the liver and Z*4% in the adrenals# . In both the 
liver and adrenals the radioactive material extracted 
was mainly * free * steroid# Bt% â 82#6>t respectively* 
After hydrolysis w'ith the enzyme preparation from 
j^^ a^tella yul.^ at,a.# which contains mainly B-gluouroniclase, 
OmB% of the conjugated material in the liver and QB% of 
that in the adrenal was extractable*
The identification techniques showed that the 
radioactivity was present mainly as 20a-dihydro- 
progesterone in the liver# whereas almost half of that 
in the adrenals was present in the form of polar 
material# (Table 45)# A similar distribution of
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Compound0 was fotmd in the 'eonjugatod^ fractions
(see Table 46)« the principal conjugated steroid in
the liver was pregnanediol whereas the adrenals contained
mainly polar compounds* Table compares the
percentage of free and conjugated steroids in the liver
and adrenals 14 min* after injection of [4-^ '^ Cî)
progesterone*
SI.MAMcMx4M-iCeseB.t_An foeMi„MMuea.^affcer g
Jiâ^JliJlisîASij2£2imst.gi^^
with [4-* ^ ol prog eat erono for 46 min*lirai»*. gat t «WKtia#;*# (»ï***ik.-îï «Sat's*
The total radioactivity recovered from the foetus
was 15$3f&*
The compounds detected in the free fi'^ action are 
shown la Table "^ *^* The main compound in the liver 
was pregnanediol and this was confirmed after recrystail- 
isation of the diacetate to constant specific activity* 
The Table shows that in many cases# progesterone was 
still the major ’free* steroid# particularly in the 
blood t where it accounted for 06# of the radioactivity 
In the first 16 min # sample and 51)4 in the 30 - 45 min* 
period* Pregnanediol was found both in intestine and 
liver ami a little radioactivity was present as 
progesterone in the liver* In the plasma samples#
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$8 the omouat» of progesterone and polar material 
deoreaoed the amount of 20a-dlhydroprotestorone# the 
prlnolpal Initial metabolite of progesterone# rose#
In the liver and plasma# the polar fraction separated 
into several oompoundo one of which was probably 
I6a hyclroxyprogoBterone and another probably 
## hydroxyprogestorone*
Therefore the main * free’ steroid in the liver in 
the first experiment was 20a-dlhydroprogesterone and In 
the second experiment pregnanediol - see fables 4lJ ê 4S 
In the adrenals most of the radioactivity was present 
as polar material in both experiments#
1 senssion
These experiments show that a large proportion of 
administered progesterone was metabolised in the foetal 
liver and this accords with the résulté of other workers 
(Solomon et al 196?)# liver deactivation of progest­
erone has been reported in vivo (Forbes & Hooker 1949) 
although not jln yi(;ro. Engel (1044)# It is not really 
surprising that the liver is one of the main sites of 
metabolism in the foetus since# in the adult a large 
proportion of the metabolites of progesterone have been
Î O I
cleteotecl in the bile (Sandberg ê\ Slaunwhite 195S|
WeiBt ot al 1958), Zander (1981) also injected
progesterone into the umbiiieal vein at termin­
ation of pregnancy and found that the majority of 
radioactivity vms present in the liver#
In both foetuses investigated the percentage of 
conjugated steroids v/as much loss than that of free 
steroids (liver oxpt# 1# 9^ fo free; expt# 2# free)#
In cxporiment I# of the conjugated material in the 
liver and adrenals 80^ 5 and 74% v/as hydrolysed by the 
enzyme preparations used# In experiment 2# ail the 
radioactivity was roleasod by enzymic hydrolysis except 
for small amounts in the liver# Enzyme hydrolysis was 
performed us 1 n g Bince this enzyme 
contains greater p-glucuronidase activity than sulphatase 
activity (toon et al Î9 00) it suggests that the 
conjugates were principally giucosiduronates particularly 
in the case of the liver# This seems reasonable since 
conjugated pregnanediol in the urine is composed almost 
entirely of pregnanediol glucoaiduronate (Cr%py at ai 
Î9G2) although Zander (1964) has found principally 
sulphate conjugation* Solomon et al (196?) isolated 
both pregnanediol glucosidtironate and the sulphate from
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the foetal liver after perfusion with labelled 
progesterone. The liver has been known to have a 
principal role in progesterone metabolism# In the 
rabbit it waa ahown to have a major role in the 
deactivation of progesterone (Maoeon & Hoffman 1945)#
In women^ it has been shown that when liver cLieease was 
present# the dlaappearanoe of added progesterone from 
the plasma took much longer and this was attributed to 
■slower Intrahepatic metabolism of the liver (Patrini#
#@64)# In the liver of the foetal and newborn guinea 
pig Pulkinen et al (196i| found that half the progesterone 
was metabolised and about one tenth could be Identified 
ae a pregnanediol-type metabolite#
In the present study* 14 minutes after injection 
of labelled progesterone the principal steroid Identified 
was 20a-dihydroprogesterone (30#5#) with approximately 
equal amounts of polar compounds * pregnanediol* 
20p-dihydroprogesterone and unchanged progesterone#
A small amount ($$) of pregnanolone was also detected#
In the second experiment 45 minutes after injection 
of the progesterone was present as pregnanediol and 
almost equal amounts of polar compounds and progesterone#
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The presence of 20a,-dihydroprogesterone and other 3a$
20a* dio.l0 was expected after the finding by Vi.lleo and 
toring (1903) of the presence of 20a hydroxy- 
dehydrogenase and 3a hydroxy-dehydrogenase in the human 
foetal liver* They had'found 20a#*dl hydro prog es t crone 
and pregnanediol ao .products of progesteronei a 
finding supported by Zander (1901)$ The latter* 
however* also detected Gg hydroxyps’ogesterone*
17a hydroxyprogesterono and 200 dihydroprogestorone 
as V'iQll as a large amount (2Q%) of polar steroids*
.Solomon et al ( 1905) detected progea.t erono*. pregnane lone* 
20a-dihydroprogesterone and chiefly pregnanediol present 
in the liver# There was no radloactivity in the 
17a hyd ro %yprog es t Crone area in the presont study or 
in that of Solomon et al (1965) hut since it was detected 
by Zander (19G1) 1 min# after injection it may he 
produced in the very early stages of the metabolism of 
progesterone*
4
In the adrenals there seemed to he more active 
metaholiem and conjugation of the radioactive progesterone 
This view is supported hy the results of Solomon et al 
( 1967)* After 14 min#* 47g& of the free "imdioactlvity 
extracted was polar material although pregnanediol*
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and unohangod progoaterone 
were also present with a email amount (6#Zj%) of 20p- 
dlhydroprogoatorono* In experiment 2* after 45 min*
60^ was present In the polar steroid fraction with the 
rest of the radioactivity a$ unohanged progesterone* 
Solomon et al (1958) after Incnhating human foetal 
adrenals with progesterone* isolated 17a-hydroxy- 
progesterone and androetenedione* and Weliky and Bngel 
(1065) found 16a-hydro%yprogesterone on ineuhatlon of 
human hyperplaatie adrenoeortieal elicee with 
progesterone* In a study of the metaholiam of 
progeeterone hy foetal testee in * Aeevodo et al
CtÔiS)* detected 16a-hydro%yprogeaterone* 17o,-hydroxy- 
progesterone* 20% end 20@ dlhydroprogeeterone and 
deoxyoorticooterone*
It is therefore evident that extensive metabolism 
of progesterone oooure in the foetus. In the liver 
reduction produoto form the main oompoundo and pregnane­
diol is a major metabolite in thia situation* In the 
adrenal glands polar compounds are formed and these have 
been shown (Solomon et al 1967) to be mainly eortiooids* 
The foetus therefore uses the progesterone it obtains 
from the placenta to manufacture its own corticosteroide*
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Since prognmnodiol has been shown to ho present An
l iq u o r  aiJîBÜ (Kloppor â Alacmaughton 1950) i t  eeomc very  
l i k e l y  that tn ia  comes from f o e t a l  u r in e  and i #  th e re  fore 
a r e e i i i t  o f  th e  f o e t a l  metahoilom o f prog 00 to rone#
It la probable that foetal progiianediol passes 
to the maternal clreolettion either across the aranlotle 
aae or via the placental circulation go that a proportion 
of the pregnanediol oxer et eel in the maternal urine 
originatoa in the foetus# it is not known what 
proportion of matepgml pregnanediol this foetal component 
forms# In early pregnancy it must bo very small since 
there io little change v/hon foetal death occurs at 
abortion unlike oestrioi excretion which falls very 
steeply,
Some Information * however* is given on this aspect 
hy Klopper et al (1906) who found that* when salino 
abortion was performed* pregnanediol output did not 
fall greatly. In seven patients the average only
fell to 78% of the prc-injection luweie with a range 
of 44 l05;oô Two patienta in fact showed no fall in
average pregnanodiol output at ail. during the injcetioa- 
abortion perIod.
Î06.
Qîimisea in pregi'ianediol excretion are not easy 
to interpret# It may be that the foetus is responsible 
for some 20fa of the pregnanocliol which appears in the 
mothers urine# The fact that oestriol output falls 
much more steeply than pregnanediol output in the first 
40 hr# after saline abortion (iclopper et al 2066) makes 
it unlikely that foetal raotaboliam of precursors is as 
important a step in the production of pregnanediol in 
the mothers urine as it is v/lth the production of 
oeatrial#
It seems therefore that the foetal metabolism of 
progesterone and the foetal production of pregnanediol 
may ho relatively unimportant as far as the maternal 
excretion of pregnanediol is concerned* The changes 
in conversion of progesterone to pregnanediol discussed 
in Chapter 4 arc probably of more importance# It 
v/as found in these investigations that particularly low 
Conversions accompanied the presence of a hydatidiform 
mole and it v/as decided to look at steroidogenesis in a 
case of hydatid!form mole in detail# Some observations 
on this subject are reported and discussed in the next 
chapter#
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CHAPTER 6.
steroid S tudieg in,, a case of, 1>y<l at ij if ora mole
It has beoe already shown in Chapter 4* that* in 
certain abnormal pregnancies* of which one variety is 
hydatidiform mole* the conversion of progesterone to 
pregnanediol is lower than in normal pregnancy, The 
question then arises as to what other pathways of 
metabolism could be occurring in these women# Stitch 
èt ai (1966) observed a considerable increase in the 
production of urinary pregnanetrio! in a case of 
hydatidiform mole suggesting that an alternative 
pathway might be favoured in this type of case*
It was therefore decided to investigate this problem 
by -
( O  determining the urinary steroids in hydatidiform 
mole and a suitable case of molar pregnancy was 
used for this purpose* 
iz) investigating the steroids present in mole tissue 
and theea lutein cyet fluid*
(3) iocuaation of a homogonatc of the mole tissue with
pregnenolono* to determine its steroid­
ogenic capacity#
Î08
Qllnioal Histwy?
A woman 4 months pregnant in her second pregnancy
was admitted to hospital with persistent vaginal
bleeding# At examination* the uterus v/as found to
be considerably larger than expected for the gestation
period# A Hogheti test was poA^formed and found to he
positive in a dilution of 1/200# A diagnosis of
hydatidiform mole was made and laparotomy performed.
At this operation a typical hydatidiform mold was
ev£icuated from the uterus; bilateral ovarian luteal
cysts were found and 200 ml# of cyst fluid was aspirated
0
and stored at -20 for later examination.
II i.0 to logical examination of the mole confix'med the
diagnosis and examination of a biopsy specimen of
ovarian tissue showed that the cysts were of the theca
lutein type#
I)etermination of Urinary Steroids
nwrmm» «*u i*    i.WMMWWtRHgailia»
I)etermination of Urinary Steroids
The urinary levels in mg/24hr# of pregnanediol and 
pragnanetriol wore determined by the methods of Kiopper 
et al (1856) and Stern (1957)#
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Injection of Radioactivity
Conversion of injected progesterone to pregnanediol 
and pregnaxietriol wao measured by using the technique 
described ear .lier in Chapter 4# Fifty micro curies 
of [ 7%-^irj prog OB tore no wore injected into the 
an te cubital vein of the mother and the steroids v/cro 
isolated from the maternal urine for 3 days after the 
injection# The tritium content of these fractions 
was then determined* These déterminations were made 
before laparotomy and evacuation of the uterus and after 
a provisional diagnosis of molar pregnancy had boon made*
Deter mi xi at ion of steroids In mole tissue and ovarian
£^i«CAlfi.wi\TJ ti.iiKa«ï>s*aWitrr»\-B»to««#»«titt>wwÈW»sw wwtoieriMBieiMiyi • rtw«a «Ker*wwwiiewww
Fifteen grams of mole tissue were incubated with 
[ 4 - ^ C] pregnenoloxie as precursor* Steroids wore 
extracted from the incubation mixture the remainder of 
the mole tissue and the ovarian cyst fluid once with 
ethanol and a further throe times with BOjâ ethanol; 
the combined eKtA‘actB wore then evaporated to dryness#
The dried extracts wore partitioned betvjeen ether 
and watOT and the ether fraction from the extracts was 
examined for neutral storoids# Preliminary fractionation
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v/as perforated by column adsorption and column partition 
chromatography and zones of individual steroids v/ere 
isolated by thin layer chromatography* Spots on 
thin layer chromatograms were Identified by spray 
colour reagents* ultra-violet absorption and gas liquid 
chromatography after elution*
The Individual metabolites fro# each of the extracts 
were chromatographed until racLio-chemically pure and 
characterised by isotope dilution or reverse isotope 
dilution* All metabolites and derivatives were 
crystallised to constant specific activity through at 
least three crystallisation steps* Where no high 
specific activity radioactive standards wore available 
identification of steroids isolated from the mole tissue 
and cyst fluid was performed using some or all of the 
following criteria^ chroraatographic mobility* 
derivative formation* ultraviolet absorption j, colour 
reactions (Zimmerman chromogens * sulphuric acid 
ehr#mogens)* and gas liquid chromatography* Quantitive 
estimations of the amounts of each material isolated 
from the mole tissue and cyst fluid were made on tiio 
basis of crystalline weights * isotope dilution studies* 
colour chromogens and ultraviolet abeorption and are
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expressed as (ig/100m.l» (cyst fliLid) and pg/lOOg v/ct v;t* 
(mole tissue)* Radioactive ssones on thin-layer plates 
wore located using a Nueleor-Ohicago Actigraph III Strip 
Scanner with a thin layer attachment « Samples for
quantitation of radioactivity were counted in henzane 
solution in a Nuclear«*Ühj.cago Uniltix Mark I Liquid 
Scintillation Spectrometer in a Bcintiliatlon fluid 
GOritain 1 ng Sg. 2 , 1 phenyloxasio 1 e (PPO) and SOmg af
‘2 2 - pa r a ph ony 1 hie 5^  ^p h onyl o xa m  I e ( POP OP )/111 re to i-uone •
The ahove is a summary of the main stops of the 
methodology involved and the full details of the 
extraction procedures^ isolation and characterioation 
of steroids^ quantitative determination of Isolated 
steroids and determination of radioactivity are given 
in the paper by Goutte et al (1BG0)#
Üx^inary pregnanetrlol ezceretion
% e  urinary excretion of pregnanetriolthe 
excretion product of Î7a-hydroxyprogOBteroxie is only 
slightly elevated in normal pregnancy (Fotherhy et al 
IS6,5) measured weeks until term# The whole
subject of pregnanetrioi excretion in pregnancy is 
discussed fully in Chapter ?•
M2#
Resuitn
The levels of urinary pregnanediol and pregnanetriol 
were 16*0 and 10* 7mg/24lir* when determined by colorimetric 
methods; 0*43 and 2*84;  ^conversions respeclively from 
injected progesterone were found#
By both methods the ratio pregnanediolspregnanetriol 
in this subject was approximately 2:1 whereas that in 
normal pregnancy is 20$1 (Harkness & Love i960)* Since 
the pregnanediol levels are within the normal range 
(Goyie et al 1950) this ratio signifies a greater 
excretion of pregnanetriol than occurs normally^ 
indicating increased secretion of 17*hydroxylated steroids
Table 49 shows the metabolites isolated after 
incubation of [4#*^^C] pregnenolone with mole tissue*
As well as unchanged p r e c u r s o r 1 7 a  hydroxyprcgnenolonci, 
progesterone^ 10a hydroxyprogesterone and 10p hydroxy* 
progesterone were isolated#
Table 50 shows concentrations of steroids and 
steroid precursors found in the extracts of mole tissue 
and cyst fluid.
Cholesterol, pregnenolone, 17# hydroxypregnenolone,
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pregnanedlol, pregnanetrlol and androatenedlone v/ore 
Isolated from both extracts# Progesterone and Its 
17a hydroxylated derivative were isolated from cyst 
fluid but not from the mole tissue in mea9%%roablo 
amount8$
Detectable quantities of oeetrogena were not 
observed in either of the extracts but colour reactions 
suggested the presence of traces of them in the cyst 
fluid extract. The maternal urinary excretion of 
oestriol was low (2$0pg/24hr*) in this patient before 
laparotomy determined by the method of Brown & Coyle (1903)*
.ISi
In a caoo of hydatidiform mole accompanied by 
ovarian theca lutein cysta a greatly increased urinary 
excretion of pregnanetriol was observed. Stitch et al 
(1900) made the same observation in a similar case and 
characterised this pregnanetrlôl as Sp"prQgnane"3a#17a, 
20a4.triol, the excretion product of 17a hydroxyprogcstcrone
Incubation of mole tissue
On incubation of the mole tissue with 
pregnenolone under conditions suitable for steroid*
1 1 4 , .
ogéaesis 17a hydroxypregnonolone, progesterone,
Hlo, hjdroxyprogeaterone and ISp hyclroxyprogesterone 
v/erc formed* Although a search was made for 17a hydroxy- 
progesterone, none v/as’^téund* It would appear however, 
that since mole tissue was able to form progesterone 
and 17a hydroxypregnenolone it should have the capacity 
for synthesising 17a hydroxypx’ogesterone* Perhaps 
on production 17a hydroxyprogesterone is metabolised at 
a similar rate to its synthesis thus preventing isolation#
It therefore seems evident from the lack of 
accumulation of 1?a hydroxyprogesteroii© that the 
increased excretion of p r e g n a n e loi Is unlikely to 
be a function of the mole tissue#
lOo. hydroxylation is an important step in the 
biosynthetic pathway to oestriol# Ci.irrent views on 
the foeto-plaoental steroid relationships at mid term 
(Solomon et al 196?) indicate that 1@a*hydroxylation Is 
a function of the foetal liver and adrenal and that this 
hydroxylated progesterone is then transported to the 
placenta# llo^ yevor, this abnormal placenta is capable 
of forming the precursor of oestriol# Tliia hydroxylation 
may only occur in the abnormal tissue because larger
1 1 5 .
quantities of precuroor than normal are being formed or 
possibly as an alternative to normal pathways which are 
ah à ont * HO 20-dihyclro progesterone a vmro f o rm ed #
The rosuits of this ineuliation shows that 
hydatidiform mole tissue:;.le active la steroWogonesls; 
it la able to form progesterone and to perform 
hydroxylations of steroids.
Steroids of the mole tlssw .»,T«tewu t t ) e-*toti<WfSW6M«i:'«œs*es«««*tniei
kevit?5 et ai C19 02) showed that the human placenta 
could not form the store.W nucleus from acetate but 
depended upon preformed precursors for feho oyntheeis 
of progesterone. In the placenta both cEnolcsterol 
(Solomon 1900) and pregnenolone (Palmer ot al 1966) 
can act as progesterone precursors. It is postulated 
that these substances are transferred to the placenta 
in the maternal blood and are retained by that organ 
for synthesis of progesterone and related hoavnooes.
From the levels of cholesterol and pregnenolone found 
in maternal blood, cholesterol would appear to ho the 
preferred precursor. In this case the synthesis of 
progesterone will p*oceed by way of pregnenolone 
(Solomon 1900}»
n o .
As well as forming progesterone the placenta has 
been shovm by studies in vitro, to contain enzyme 
systems capable of metabolising progesterone .to 30a* 
d ihyd ro prog e s t eron e and Î 7a*liyd ro xyp ro ge s t e rone 
{tittle et ill 1959; tittle & Shaw 1961), 16a*hydro30^ * 
progesterone and androstenedlone (Little et al 19 63; 
Warren & Cheatum 1904) and 6p*hydroxyprogesterone 
(Berliner & Oalhaniek 1956)#
From the abnormal trophoblastic mole tissue 
cholesterolp prognenoione, 17a hydroxyprognenolone, 
pregnaaediol, pregnanetriol, aadrostenedione and a 
trace of progestérone were Isolated* Although Pearlman 
and C'erceo (1052b) observed that successful extraction 
of progesterone from placental tissue required a high 
pH, it is not felt that poor extraction was responsible 
for the low level of progesterone found, since Qreig and 
Maonaiighton (19 67) * . see chapter 5 * used à similar 
extraction method to that used here and also because 
progesterone was isolated from the ovarian cyst fluid 
by the same methods* Failure to extract a substance 
from a tissue does not necessarily indicate lack of 
synthesis of it hut in the light of the amounts of 
progesterone isolated from placental tissue in previous
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studies (Chamberlain et al 1906a) it ia concluded that 
in thiB hydatid!foi'm mole there was a decreased 
Gynthesis of placental progesterone* This might reflect 
a lowered placental function or could mean that part of 
the placenta had regressed or separated from the 
uterine wall and that only the remainder was capable 
of producing steroids. The lowered progesterone 
production must be equated with the normal pregnanediol 
levels found in this patient end this will be discussed 
later. 20o,*Dihydroprogesterone was not found In the '
mole tissue and neither was 17a*hydro%yprogesterone 
although 17a*hydro#ypr0gnenolone was identified. 
Pregnanediol and pregnanetriol, the saturated reduction 
products of progesterone and 17a*hydroxyprogesterone 
respectively# were both identified. Pregnanediol is 
a normal constituent of placental tissue (Pearlman and 
Cerceo 19S2o) and the presence of pregnanetriol was not 
surprising since the patient excreted large quantities 
of this substance in her urine#
It is concluded from these studies that the mole 
tissue wae capable of steroidogenesis but there was 
less synthesis of progesterone than is normal; there
l i a .
was also an accompanying lack of the normaJ* hydroxy*
1 at8(1 derivatives of progestérone • Chamberlain
et ai (lS68b) using gaB*J.iqiiid chromatography have 
at ml led extracts from three separate moios* Although 
these workers found more progesterone than observed in 
this study they also eoneluded that the abnormal tissue 
produced less progesterone than normal. Mo 1 7ci*hydroxy- 
progesterone was extracted from the mole tissue and 
only a small amovjnt of 17o»*hydroxypregnenolone.
Although a smoJJ. amount of pregnanetriol was isolated 
these findings lend support to the conclusion drawn from 
the incubation experiments that the increased urinary 
excretion of pregnanetr1oÎ in this case of hydatidiform 
molo did not originate from the mole tissue.
3toroids in ovarian cyst fluid
Cholesterol, pregnenolone, 1 7ci*hydroxypregncno 1 ono, 
progesterone , 1 7a*hydro)syprogestorono, pregnanediol, 
pregnanetriol and androstenecllone were Isolated from the 
ovarian cyst fluid. The compounds isolated from the 
C5^ st fluid were the same as those found in the mole 
tissue with the addition of measurcable amounts of
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protestoron© and 17#*hydroxyprogestcrone. Apart from 
the precursors choleaterol and pregnenolone, all other 
GUhstancos isolated were found in much larger 
quantities than in the mole tissue, (Table 50>*
These results suggest that the increase in 
l7*hydro;iylation which was signified by an increased 
urinary excretion of pregnanetrlol, is ovarian in 
origin# This conclusion would he in agreement with 
the findings of Stitch et ai (Î90O) who observed that 
pregnaneti'^.iol excretion remained high after evacuation 
of the uterus until regression of the cysts*
In hydatid iform mole the trophoblast produces 
large quantities of human chorionic gonadotrophin 
(l!«CsG«) - the Hog ben test was positive in a dilution 
of 1&20Q * and it is probably as a result of over* 
stimulation by this hormone that the ovaries became 
cystic# These ovaries were stimulated to produce 
17a*hydroxyprogeGterone* Evidence for the secretion 
of a pregnanetriol precursor by the ovary is given by 
Fotherby (|9G2) and this will bo discussed in the next 
Chapter when the ovarian production of hormones is 
considered following stimulation with human menopausal 
gonado tro phin#
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CllîoXostoroi from the maternal blood or ovary le 
probably need ao the precursor of 17««hydro%y storoids
and overs Simulation would reeislt in increased production
of all the intermediates in this pathway ^ pregnenolona^ 
$7a*hydroxypregnenolone and progesterone «• as well as 
the excretory product, pregnanetriol# - Fig. 0*
The polycyotic avaries produced m m l l  quanti ties 
of onoro8tonedione hut -no traco ^ of tootostorone was
famid in the o.yot fluid@ The fact that the ovarios 
arc not stimulated to produce oestrial is in agreement 
with the findings of Frandoen (1005) and the lowered 
urinary cxcrotion of oestrioi frequently found in many 
cas03 of hydntidiform mole, also observed In this caoo 
and doscribed in oomc detail in chapter 8* This is a 
further factor which supporte the hypothceia that the 
proeonco of foetal proourooro of oestrioI are ncceaeary 
for the increased production of oostriol in pregnancy#
Ttio .normal pregnanediol levels found in such a 
case may be misleading since they may reflect normal 
placental function^ or may indicate Imvorcd placental 
function at the same time as an increased ovarian 
production of progesterone which may mcplain the
1Z1
findings reported in chapter 3, where' the pregnanecliol 
love Is in cases of hydatidiform mole vary from low to 
normal *
Oonei Its ions
From these investigations the following concluslone 
may he drawn (1) there was an increased urinary 
excretion of pregnanetriol (2) the mole tissue was 
active in steroid metabolism producing î7a-hydroxy* 
pi’egnonolonej progesterone, 16a--hydroxyproge6terone, 
and 16p*hydroxyprogoaterone from pregnenolone, but 
apparently less progesterone than a norraal placenta#
The increased urinary excretion of pregnantetriol is not 
a function of the mole tissue (3) the high urinary level 
of pregnanetriol is probably of ovarian origin (possibly 
ae a result of overstimulation by the high levels of 
H*C*G# present).
The effect on the ovary of the high levels of 
il#0*G# produced by the molar tissue is of particular 
interest# In the therapy of some amoriorrhooic women 
combinations of follicle stimulating hormone and H.C#0# 
are now in regular use for the induction of ovulation* 
One of the most troubleoeme complications of this
1 2 2 .
thürapy is hyperstimulation of the ovary* The 
fiyndrome, as far as the ovary is concerned. Is analogous 
to that produced by the II*C*G* from a hydatidiform mole* 
fhe results of this molar Investigation arc now 
applied, in the next chapter, to women being treated 
with human menopausal gonadotrophin and their relevance 
to the measurement of corpus lutcum function in those 
women is discussed*
12ù *
ürlnaryBteroM exeretlon after
In the previous chapter It %vas suggested that the 
high level of pregnanetriol In the urine of women with 
hydatidiform mole has it$ origin in the ovary* It 
la produced in the theea lutein cyete of the ovary 
ivhich are caueed by the large quantities of II.G.G# 
present in the circulation of these women and does 
not result from metabolism occurring in the trophohlast 
itself# These findingo are relevant to early 
pregnancy induced by human menopausal or pituitary 
gonadotrophins where hyper stimulat ion of the ovary 
frequently occurs# due to excessive dosage of 
gonadotrophin* This is a very similar situation to 
that found in the hyperstimulated ovaries in 
hydatidifo rm mole*
The information obtained in the previous chapter 
has been applied to the study of a small number of 
women in whom ovulation was induced by human menopausal 
gonadotrophin and this work forms the basis of this
i?A>
chapter# These results are as yet ratlier preliminary 
but are of coneldarable Interest and It Is felt they 
are worthwhile discussing in this thesis# They both 
help to round o#' the work reported and at the same 
time pose a number of problems for future work* To 
put the position of pregnanotriol into perspective 
some aspects of steroidogenesis in the human ovary 
ivill first be discussed#
Sterqidogenesis in the human ovarz
The iMsman ovary is capable of synthesising 
cholesterol from acetate probably by the same route 
as that established for hepatic cholesterol synthesis 
(Popjak and Gornforth 1900)# Pregnenolone is formed 
by splitting off the side chain and progesterone is 
formed from pregnenolone by removal of 2 hydrogen atoms 
and the shift of the double bond from the delta 5 to 
the delta 4 position# The steps of the biosynthetic 
pathway to oestrogens are shown in the diagram (Fig# 9 )$ 
The relative importance of the several alternative 
routes from pregnenolone to ocstradiol are not known 
in any detail# There is some evidence that in the 
follicle# oestradlol may be formed by a pathway not
Î 2 5 .
Involving progesterone# whereas in the corpus luteum 
a pathway involving progeatorone may predominate 
(Ryan and Petro $006).
c^strioi.i As has been said earlier in this thesis 
oestriol is present in .large quantities in human urine 
and if oestradioi is given to a woman a considerable 
pro portion of this material is excreted, in the urine 
me oestrioi# The conversion of oestradioi into 
oestrioi occurs in the maternal liver and oestriol 
has usually been considered to bo a catabolic product 
of oestrone or oestradiol* It has also been thought 
to be a detoxication product because its oestrogenicity 
is loiver and it is more soluble in wator than the other 
two classical oestrogens* There is, however# evidence 
that the ovary does secrete oestriol# especially during 
the lt:teal phase of the cycle (Barlow and Logan $966) 
and the ovary has been shown to contain a Ida hydroxylase 
Oestriol may therefore be considered an ovarian 
oestrogen in its own right. It is not yet cloar 
whether# as in the liver this ovarian oestriol is 
formed from oestrone and oestradiol or whether# as in 
the placenta from $6% hydroxy dehydroepiandrostorone.
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Oontrol of ovarian biogonesis
The pituitary gland secretes trophic hormoneo 
which stimulate the endocrine glando to produce their 
reapeetive hormones * Follielo stimulating hormone 
(F*8$II#) atimuiatea follicular growth and results in 
incroaaed oestrogen excretion# In this sense F#S#h# 
stimulates oestrogen production but it is not cloar 
that it has any specific effect on steroidogenesis#
At the menopause# for example# high levels of F#S#H# 
are associated %vith lo%v oeatrogen levels because of 
the absence of growing follicles#
In ,vitrp preparations of F#8*tl# have been reported 
to stimulate the rate of conversion of cholesterol to 
pregnenolone in non pregnant bovine corpora lutea 
(ichii et al 1903)# but these results could not be 
reproduced (Yago et al 1967)# It is also impossible 
to obtain pure F#$#H# i#e# not containing a proportion 
of Luteinising hormone (LH) and it cannot therefore be 
Said that any action due td this F#S#h# is due to this 
material alone since it might be due to the Lh 
Contamination#
In contrast there is considerable evidence that
127#
Loll* can specifically influence ateroidogeneais (Bavard, 
et al I060I Channing and Short 19 66)• It has the 
effect of increasing both the rate of conversion of 
cholesterol into progectorone and the de-novo
production of the latter*
In early pregnancy, it may be a specific action of 
chorionic gonaclotropUin on steroidogenesis that 
maintains production of progesterone and oestrogen 
by the corpus lute urn* Tho L.IÎ* peak in the inenstrual 
cycle (see Fig*10) is of short duration and occurs 
near the time of ovulation and not in the luteal phase 
of the cycle (Midgley and Jaffe 1966)* It appears to 
bo associated with ovulation and possibly with corpus 
luteum formation but does not appear to maintain steroid 
secretion during the luteal phase* There does not 
scorn to be a sharp decline in L*H. associated with the 
decline of the luteal steroidogenesis and it is 
difficult to explain how rising levels of chorionic 
gonadotrophin continue the life span and steroid 
secretion of the corpus lutoum when conception occurs# 
The presence of a uterine luteolytic factor, for which 
there is evidence in several animal species (Short 1966)
U B .
does not seem to obtain in the human and removal of
the uterus appears to prolong the life of the corpus 
lut cum by only a few clays (Andreoii 1965)*
The effoet of gonadotrophins on ovarian cellular 
metabolism vlvq is almost completely unknown although 
the resultant steroid excretion is well documented, e*g# 
Loraine and Bell (19 68), at any rate as far as 
oestrogen and prognanecllol are concerned# Where 
other steroids and particularly pregnanetriol are 
concerned evidence is much more scanty*
The other steroid of particular interest is 
pregnanetriol (5p-prognanG-3o.# I7a,20a--triol) and its 
origin and excretion in the menstrual cycle and in 
pregnancy will now he discussed#
In the biosynthesis of the steroid hormones 
17c. hydroxyprogesterona is an important intermediate 
(Samuels 1960)# The principal urinary metabolite of 
17(& hydroxyprogGstorono is pregnanetriol (Axelrod and 
Gold si eh or 1960; Fukiishlma ot al 1961)#
There are three possible precursors of pregnaaetrioi 
namely, 11-#deoxycortl8ol, 17a Eiydroxypregnenolbne, 
and $7o, hydroxyprogesterone# Fotherby and Love (1DG0) 
studied the conversion of these precursors to 
pregnanetriol and found that by far the greatest 
conversion occurred when 17a hydroxyprogesterone
was injected# These worke%*s concluded that 
pregnanetriol %vas therefore the main metabolite of 
17a hydroxyprogesterone#
îiie«.21ar|jin^gî;;od«ctAos^,,|_a
It has been suggested (Brown 1050) that ovulation 
occurs at about the time that the excavation of oestrone 
and oestradiol reached a maximum towards the end of 
the follicular phase of the menstrual cycle* The data 
of potherby (1062) showed that there was a significant 
rise in pregnanetriol excietion on the day that the 
excretion of oestrone and oestradiol reached a peak#
The magnitude of the rise suggests that the precursor 
responsible in the second half of the menstrual cycle 
was 17a hydroxyprogesterone since oestrogen levels are 
lower at this time* I7a Hydroxyprogesterone is kno%vn 
to be secreted by the adrenal cortex and the majority
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of pregnanetriol in the urine may arise from this 
source* From the day of ovulation this adrenal 
prcgnanetrloi is supplemented by some arising from 
precursors secreted by the ovary $
Although the evidence (Fatherby 1962) suggests 
that the increase in prognanetriol excretion in the 
menstrual cycle (Fig# 11) is due to an increased 
secretion of precursor from the ovary it could possibly 
he due to increased adrenal production at this time* 
llowever, that the ovary is responsible, is supported 
by the fact that the biosynthesis of oestrogens from 
cholesterol involves 17a hydroxyprogesteronc as an 
intermediate (see Fig* 9 ) (gyan and Smith 19 65') and 
this steroid has been identified in extracts of human 
ovaries (bander 19 58) and in human follicular fluid 
(Short and London 1961)* Further support for the 
ovarian secretion of a pregnanetrioi precursor is 
provided by Fotherb^^ (19 62) who administered nor- 
ethisterone to normally menstruating women and found 
that the rise of pregnanetriol excretion in the second 
half of the cycle did not occur* Since the second 
oestrogen peak and the pE^egnanediol peak did not
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occur in these women® Fotherby (10 62) concluded that 
the decrcase in the excretion of pregnanetriol during 
the administration of the synthetic steroids was due 
to a suppression of procursors from the ovary which are 
metabolised to prognaaotrlol viz 17a hydroxyprogestorone 
in the cor pus lutcum#
It would appear, therefore, that the excretion of 
pregnanetrial in the urine might give some estimate of 
the corpus lutcum activity of the ovary and that this 
might be a valuable steroid to measure In the urine in 
early pregnancy#
Pregnanetriol excretion in human pregnancy
The most reliable estimates of urinary pregnanetriol 
output dux'ing normal pregnancy are probably those of 
Harkness and Love (19 06)# Previous methods i#e#
Potherby and Lovo (19 60) wore probably not specific for 
the determination of pregnanetriol in the urine of 
pregnant v/omen (Fotherby et al 1905)* These previous 
methods (Bongiovanni and Clayton 1954; Stern 1957) 
used a sulphuric acid colour reaction for estimating the 
steroid and there arc compounds present in the urine of 
vmmen during pregnancy that interfere with this colour
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reaction. Those interfering sulphuric acid chromogens 
in pregnancy urine increased with duration of the pregnancy 
and Fotherhy et al (1965) found that at least some of the 
interfering compounds in pregnancy urine are polar 
metahoiitea of progesterone* In non-pregnant women 
and in early pregnancy the method of Fotherhy aEid Love 
(10 60) is suitable since the amount of interfering 
substances is minimal *
In their paper Harkness and Love (1060) measured 
urinary pregnanetriol excretion in the urine after the 
22nd week of pregnancy and Fig * 12 is taken from their 
results. This shows an increase in the last trimester 
reaching a maximum at about 30 - 3 7th weeks of pregnancy* 
There were large variations between individual patients*
The increase found by these workers was not so great 
as that described by Herrmann and Silverman (1953) and 
Honan et al (i960)* llarkriess and Love ( 1966) also 
estimated pregnanetriol excretion during pregnancy in 
an adrenalectomisod woman and found that the level also 
increased. They suggested that the focto-placontal 
unit is probably the source of the increased amounts of 
urinary pregnanetriol in the adrenalatomisad pregnant
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woman and presumably it is also the origin of some of 
the increase observed in normal pregnant women in the 
second and third trimesters* The occiirrance of the 
rise in the last trimester of pregnancy suggests that 
the foetal component of the foeto-placentai unit may 
be the more important sonrco of the increase in tu .tnary 
pregnanetriol* This suggestion is consistant with 
the scheme proposed by liiczfainsy ( 10 64) for the 
steroid metabolism of the focto-placental unit at t)ld 
pregnancy*
All the workers already referred to have measured 
the urinary excretion of prognanetriol from raid pregnancy 
and there is no information as to what happens' in very 
early pregnancy#
It is well Known how difficult it is to obtain 
information at very early stages of human pregnancy hut 
the advent of gonadotrophin therapy for stimulation of 
ovulation in amenerrhoeic women has meant that a number 
of women are under observation at the time of conception 
and during the very early stages of pregnancy« It is
therefore possible to measure urinary steroids in these 
patients in the cycle in ^vhieh pregnancy occurs and
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observa the changes which take place in steroid 
excretion at this very early stage of pregnancy, wheiip 
in fact impIan tation and the growth of the blastocyst 
are talcing place* It is at this time that the corpus 
Inteiim of pregnancy, in the h u m a n i s  of some importance 
Since after 3 5 days, it has been shown by Tu 1 sky and 
Koff (1957) that human pregnancy can continue even If 
the corpus luteum has been removed*
Gi.i nieal II1 b to ri eg of Patients
Oaae Mo* 1* f*ll« Age 34, Secondary ameriorrhoea for
8 years*
The menarChe occurred at the age of Î4 years and 
the menstrual cycle v/as regular at first* At the 
age of 18 years it became .less regular and finally 
stopped when the patient was 20 years old#
She was first seen at the age of 34 years and 
tested for suitability for gonadotrophin therapy* The 
details of this investigation are not pertinant to the 
aspect of the subject be.lug discussed and will not be 
given here* She was Judged to be suitable for the 
induction of ovulation v/ith human menopausal 
gonadotrophin*
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This patient became pregnant after treatment 
and abortion occurred at about 2-3 months of pregnancy *
In a second pregnancy twins wore conceived* This 
pregnancy proceeded to term when she was successfully 
delivered by Caesarean Section*
The results of steroid excretion assays during the 
aborted and W i n  pregnancy will he discussed*
Case Mo# 2* II* dl F* Age 27 yrs* Secondary aimenorrhaaa 
for 4 years following the birth of her only child*
the menarchè occurred at age lo years and her
menstrual cycle was regular until her first pregnancy 
occurred at ago 23 years* The pregnancy was uneventful 
and she had a normal delivery at term with no
complications* Menstruation did not return and after
4 years Btie was tested for suitability for gonadotrophin 
thcrapy and found to be suitable*
She was treated with human menopausal gonadotrophin 
In a number of cycles before a pregnancy occurred* In 
the first half of this pregnancy she had intermittent 
vaginal bleeding and rested in hospital for prolonged 
ariods at this time* She remained well during the
ÎS6»
middle trimester of her pregnancy and then had further 
bleeding and v/as admitted to hospital again for rest 
and supervision at 34 weeks# She was delivered 
successfully by Caesarean Section at S9 weeks of 
pregnancy. The results of steroid excretion in a 
cycle and during the early part of pregnasiey will be 
discussed #
Case No# 3# 3#F# Age 52 years# Secondary
amenerrhoon for 7 years#
The menarcho occurred at the age of 13 years and 
the menstrual cycle continued to be fairly regular 
until the age of 25 when the amount of bleeding
became scanty and menstruation finally ceased altogether#
!
This patient v/as 'foimd to be suitable for 
gonadotrophin therapy and several cycles of treatmexit 
have been given#
The results of steroid excretion during these 
cycles will be diecussed.
Case No # 4# G#H# Age 35 years# Nullipara#
This patient suffered from severe endometriosis 
and total hysterectomy and bilateral salpingo-
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oopherectomy wore performecU She kindly agreed to 
cooperate In an experiment to determine the effect of 
administered F.S #H# and t.O* to an oopho recto raised . 
v/oman® She was given 760 lU# plus' $000 ID.
Sl.C.O# and her urinary steroids were measured for 
14 days thereafter. The object of this experiment 
was to find out whether pregnanetrioi excretion rose 
after gonadotrophin stimulation in the absence of the 
ovary i.e. ivhother aome of the increase was due to the 
adrenal•
Assay methods; Urinary prognanedlol was measured by 
the method of Klopper et al i^9B5)p and urinary 
oeatriol by the method of Drown (1055) as modified by 
B row» e t a 1 ( Î 0 5 7) » P regaa ne t r io 1 wa s me a a nr ed by 
the method of Fotherhy and Love (1000)'which- is.
8uitable for measuring this substance In the non- 
pragEiant state and in early pregnancy where there is 
little interference with the sulphuric acid colour 
reaction.
Results:
Fig. 13 shows the pregnancdiol excretion and the 
oestriol excretion in 48 hour urine specimens in Case
1S8» «
No. I .in the pregnancy in wh.ich abortion occurred.
The levels of both hormones rose to above nou"pregnancy 
levels until bleeding occurred (Bj after which time there 
was a gradual fall in both eteroids^ the ^Oravindex* 
pregnancy test became negative and abortion finail,y 
took place.
Fig. 14 shows the first 20 weeks of a twin pregnancy 
which resulted in a successful conclusion* In this 
pregnancy the excretion of oestriol and pregaanedioi 
rose in the usual manner associated with early pregnancy 
and the hormone pattern in the urine remained normal 
till tcx*m«
Fig. 15 shows the excretion of pregsianecUoi^ 
pregnanetriol and oestriol in a gonadotrophin stimulated 
cycle in Case No. 2. Only I oestrogen pealc is
present in this cycle and there are peaks of 
pregnanediol and prcgnanetriol after ovulation there­
after the levels falling toward the end of the cycle*
Fig* 16 shows the excretion of these three steroids 
in the urine of Case No. tp in the cycle in ;vhich 
pregnancy occurred and the .excretion thereafter till 
30 weeks gestation. There is a fall in ocstriol
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after 5-0 weeks of pregnancy but the level then begins 
to rioo again to normal pregnancy levels. Pregnanedial
excretion follows t he.oame pattern with a fall to 
relatively low levels at about 12 weeks - it was during 
this time that bleeding occurred and there may have 
been deficient steroid biosynthesis in the trophoblastic 
tiaaiie around this time accounting for the fall in the 
urinary excretion of steroid metabolites.
The excretion of pregnanotrioi in this case also 
rose pare passu with pregaanediol up to 6 weeks of 
pregnancy and then foil to the levels usually reported 
for human p regnan ey•
■ Figs# t?p 18 and 18 show the excretion of 
prognanediolÿ pregnanetriol and oestriai in 3 
consecutive cycles stimulated by gonadotrophin therapy 
in Case No# 3. In the 1st. and 3rd * cycles the response 
is more marked than in the 2nd. cycle and this confirms 
the variability of response by the same woman to the 
same dose of gosiiadotrophin in different cycles that has 
been commented upon by Grooke et al (19 86) and others.
Fig. 20 showB the urinary excretion of the three 
hormones in the urine in Oaao No. 4# where the ovaries
140.
wore absent. There is a little rise in oestriol 
exeretxoa but little change in the excretion of 
pregnanediol ami pregnanetricl.
EU£M£8|^0B
In Fig. Î3 where abortion occurred the initial 
levels of oestriol and pregnanodiol rose as would be 
expected in normal pregnancy. At about 60 days 
gestation there was some bleeding and thereafter the 
levels of hormone excretion fell. It seems probable 
that when bleeding occurred there was some disruption 
of the trophoblast which resulted in death and 
subsequent falling of the levels of urinary metabolites 
of the hormones manufactured by the trophoblastic 
tissue#
This ease confirms the results discussed in 
Chapter 8 p and shows that measurement of these two 
metabolites, vis, preguanediol and oestriol, in the 
urine during pregnancy, is not likely to give an 
indication of impending abortion. This result would 
indicate that, at this stage of pregnancy when abortion 
occurred the ovarian contribution to the level of these
Î41
steroids in the maternal urine must be minimal# 
Dlesfalusy and Boreil (10 01) measured the output 
of ooBtrogens and pregnanediol before and after 
removal of the ovary seventy eight days after the 
date of the last menstrual period# In the removed 
ovary theye workers found a fully mature corpus iuteum 
of pregnancy. Since the level of both the oestrogens 
and pregaanediol remained the same after oophorectomy • 
indeed that of pregnanediol actually rose after the 
operation - it v a^s concluded that during the third 
month of pregnancy a histologically mature corpus 
lutcum of pregnancy did not seem to be a significant 
source of urinary oestrogen and prognanedioi.
It may be true, and seems likely, that at even 
earlier stages of pregnancy the ovarian contribution 
may be significant^ but this would appear to be at very 
early stages only.
The pattern of excretion in the twin pregnancy is 
shoxvn in Fig# 14 . There is a steady rise in hormone 
level# The levels in this case are rather higher than 
those reported for twin pregnancy* Gem%ell and lioos 
(Î960) found the average excretion of prognanodioi to
Î 4 2 » .
he almost the sarae in those women who conceived a 
single infant or twins bmt was ©ignifioantiy higher 
only iu those women ooncoivlng triplets or more 
foctiisos# On the other hand the avoroge excretion 
Of oestrogen has been found by these workers to be 
somewhat lower in those women who gave birth to a 
single infant than in those who gave birth to twins, 
triplets or wore foetuses# The findings in the 
present patient would support this view# Unfortunately 
the level0 of prognanotriol wore not available in this 
woman#
PregnanetrioI excretion in the gonadotraphia
SMSElâÊJ.l»£iaM
fho origins and precursors of urinary pregnanetriol 
have already boen discussed# Very little information 
is available in the literature about the excretion of 
pregnanotrlo1 in the urine of women being treated with 
gonaclotrophino although much has boon %vritten about 
0estrogens and prognanodioi (toraino and Beil $968)# 
Lorain0 ot ai (1060) have reported a few cycles of 
pregnanetriol excretion in women who havo been given 
clomiphene for induction of ovulation# and the pattern
14S.
in those cycles has been of the same order as that 
found in the normal cycle where stimulation has been 
by endogenous gonadotrophin#
Four gonadotrophin stimijilated cycles are shown 
where the levels of pregnanetriol have been measured 
in the ux'lno. Figs# 15, 17, 18 & 19. Three 'of these 
( 17# 18 & 19) v/ero successive cycles la the same woman 
and the fourth ( 15) was in m patient who became pregnant 
in a subsequent cycle#
The results show that in the gonadotrophin 
stimulated cycle the urinary excretion of pregnanetriol 
rises during follicle growth and is greatest Just after 
ovulation i.e. betv/een day 14 and 16 when the corpus 
luteum is most active*,
As has been mentioned before the principle precursor 
of Pregnanetrio1 is I?a-hydroxyprogesterone {Fotherby 
1962)# Strott and Lipsett (1968) have shown that 
there is a significant clifferance in plasma 17a-hydroxy- 
progesterone levels between women in the follicular and 
luteal phases of the menstrual cycle# These workers 
indicate that the higher 1 ?G,-hydroKyprogesterono levels
1 4 4 -
during the luteal phase of the cycle suggest that the 
corpus iutemn la the source of the 17a-hydroxy- 
progestorono* There is no doubt that this steroid 
is accreted by the ovary and Mikhail et al (1963) 
showed that the levels of 17a-hydroxyprogeoterone in 
ovax'.ian venous blood were 60 times those found in 
peripheral blood thereby proving ovarian secretion of 
17a-hydroxyprogesterone* It is notable that in 
Case 4, where the ovaries are absent, there is no rise 
in the level of pregnaoetriol following administration 
of F*S*lî* and Loll. This gives further support io 
the ovarian origin of the increased amounts of this 
Bubstance found in prâno daring the menstrual cycle*
The suggestion therefore is that the corpus 
lutcum does in fact seerete moderate amounts of 
17a--hydroxyprogesterone and this accords with the 
findings reported in Chapter 0, where this cooipoimd 
was detected in the theea lutein cyst fluid from a 
woman with hydatidiform mole* 'That the secretion is 
from the corpus lutcum is further supported by the fact 
that in men, where the levels of 1?a-hydroxyprogeBtoronO 
are higher than those in the follicular phase of the
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cycle in women, there .is a substantial increase in 
urinary pregnanetrio1 following the administration of 
Human Chorionic Gonadotrophin to normal men (Jaylo 1965; 
Landau and Lanes 1959). There appears to he a 
gradual decline in steroid synthesis in the corpus 
Xnteum during the luteal phase of the cycle since the 
level of both pregnanediol and prognanetrio.l fall 
together# other evidence that this ie so is based on 
the progesterone content of the tissue, and the 
progesterone content of ovar.I.an and peripheral venous 
bleed (Zander et ai, 1958; Mikhail et al, 1963)#
On the other hand recent work by Le Maire et al (1968) 
on measurement of progesterone synthesis in the corpus 
lutcum failed to reflect the expected gradual decline 
through later phases of the menstrual cycle# These 
v/orkers found that only the abrupt complete failure of 
corpora .latea, 14 days and over, to incorporate 140 
acetate, accorded with previous observations of 
cessation of fonction of the corpus lutcum at the end 
of the cycle# The reasons for this latter finding 
are not clear but an obvious shortcoming of in vitro 
studies of the type performed by Le Maire et al (1908) 
is the great variability in the synthetic capacities
#46-
of imlivldtiaJt from different patients# a
factor which lg$ absent from oeqnontial stiWiea conducted
in the saue patient-# flüs of courso is Impassible
do in the human out je et-*
W i m m s M â R i .
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Xîï the paf.iG'fits who "feocamo pregnatît the .levels g I ‘ 
oaatrioiÿ prognanetriol mid prognanodioi rooo together 
following ovarian stimalatimi by PoO.Ho and
intorc$6Ling features are that^ y tiw prognonotrlol 
iavel rooo to over iOmz/?A hr#, vory much lUgUep than 
any previouai^^ reported in prognancys The
ievci of aii throe hormones thoa foil and at this time 
the patient was resting in hospital with threatened 
abertiei'%t% The lovoi of oestriol and pr#gnaaedloi 
thoroaftcr rose to the ncnmi figuras found in pregnancy 
and tho iQVol of prognsnota'iol remained at that 
ropot^tW for progiiaaoy hy ps'Wioim authors and dAseuosed 
curliar#
The suggestion is therefore made that this high 
MluetiOR of pregnanet.rlol at this very early stage of
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pregnancy is a function of the corpus Xoteum of
pregnancy and that the amount found does, in fact, 
give a measurement of this corpus lutcum activity.
A second patient (Case 3) has recently become pregnant 
and has shown the same findings in very early pregnancy.
. It has been difficult to assess clireetly the 
function of the corpus luteum of pregnancy* Ovarian 
and peripheral venous progesterone levels have been 
measured at intervals throughout pregnancy (Mikhail 
and Allen 19 67) and this data suggested that the corpus 
lutcum was the important source of pragesterono during 
the first 12 weeks of pregnancy. More recently 
Yoshima et al (1960) have mensured plasma 1 7o,-hydro%y- 
progesterone in women who became pregnant after 
ovulation v/as induced with gonadotrophin* Since the 
placenta has no or only very limited capacity for 
17o,hydroxy 1 at ion (Palmer ct ai 1966; Jungmann and 
Scîliweppe 10 67) measurement of plasma 17a-hydroxy- 
progesterone or its main urinary metabolite 
pregnanetriol should reflect corpus luteum function*
The findings in the present case fit exactly those of 
Yoshima et a.I (19 69). These workers found that the 
peak of plasma 1?a-hydroxyprogesterone vms between
1 4 8 .
4 and B weeks of gestation and by 12 weeks this 
compound had stabilised to a level which was 
maintained for the remainclor of the pregnancy (Fig. 21). 
Plasma progesterone, on the other hand rose to a 
peak about 3 - 4  weeks aftex' H.C.G. The level then 
fell reaching a nadir at six to eight weeks. This 
was foilov/ed by increasing levels, almost certainly due 
to placental production of progesterone.
Koto on the functional life of the corpus iuteuBi of
The functional life of the corpus lut cum of
pregnancy in man has given rise to controversy over 
the years. Scattered reports indicate that its 
function may not be important to the continuation of 
pregnancy after 6 weeks, (Deansly 196G), but as has 
been suggested earlier in this chapter the work of 
Tulalty and Koff (1957) and Froov/is (19 63) indicate 
that abortions tend to occur after removal of the 
corpus lutcum during the fifth to sixth week after 
conception whereas after the sixth week there were no 
t.pontaneoiis abortions. These data are consistent 
with an early important role for the corpus luteum.
1 4 9 .
It does not, however, help v/i,th respect to
Continuing corpus inteiim function in pregnancy* 
Histological studios of the corpus lutcum of pregnancy 
showed the persistence of granulosa lutein cells 
throughout pregnancy (Oillman et al 1941). These 
seemed to reach their greatest development between the 
second and third month and to disappear shortly there­
after, Nelson and Greene (1958) after extensive 
study concluded that the corpus lutemi of pregnancy 
actively flourished and was functional during the 
first six weeks of pregnancy, deteriorated markedly 
from the 8th to the 16th week and was passively 
maintained from then on until the termination of the 
pregnancy# These workers concluded that the ovary 
during the larger portion of pregnancy appeared from 
a histological point of view, to act only as an end 
organ influenced hy extrinsic substances probably of 
placontal or1g1n.
Elevated plasma 1 ?a*»hyciroKyprogeBterone levels 
wore found In the luteal phase of the cycle (Yoshima 
Ct al 10 69) and these workers found that the plasma 
I'/a-hydroxyprogesterone level was a good index of
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follicular development and luteal function* They
suggested that they could examine one aspect of 
steroid production by the corpus luteum in the presence 
of a functional placenta* They estimatedfrom the 
divergence of curves of plasma progesterone and 
Î?a-hydroxyprogcsterone (Fig. 22), that the life of 
the corpus lutetim of pregnancy was about 10 weeks.
I f t h e r e f o r e , the pi as m a 1 hyd r o xy p ro g este ro no 
does monitor the early corpus lutem^, and the evidence 
that it does seems good, then the main metabolite 
pregnanetriol could also be used in this way. The 
evidence of the present two cases suggests that it does 
and therefore it is put forward that the measurement 
of pregnanetriol in the urine in very early pregnancy 
may be helpful in monitoring abnormalities of early 
■pregnaBicy clue to deficiency of corpus iiiteum function 
such as early abortion*
During the first six weeks of gestation the 
corpus lutcum is the predominant source of progesterone 
and after the nadir of plasma progesterone is reached 
the placenta assumes the important role in progesterone 
production. The occurrence of the nadir in the plasma
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progostorone curve suggests that this should be a 
critical period in pregnancy since cither an unusually 
rapid fall in progesterone production by the corpus 
luteom or a too slow increase in placental progesteroin 
production could result in plasma progesterone levels 
incompatible with the continuation of pregnancy* The 
value of urinary pregnanediol measurements in early 
pregnancy have been shown earlier in this work to be 
unreliable In forecasting abortion and giving 
information about the corpus lutcum, and it is now 
suggested that urinary prognanetriol estimations 
ohould be used instead unless suitable methods of 
assay of pXtisma levels of hormones can be developed 
for this, but this involves more complex methodology 
and repeated veni puncture*
One point which must be noted, however, is that 
urinary pregnanediol excretion is well known to be 
greater after induced ovulation than after normal 
oVulatioa {Geinzell 1965) * The levels of 1 7-hyd ro xy 
progesterone and progesterone noted one week after 
ovulation induced by gonadotrophins were higher than 
those seen at a comparable time of the normal luteal
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phase and the levels of pregnanetrlol seen in the
lULine in the present cases are also higher than those 
previously reported•
These higher levels may be due to multiple corpora 
lutea, or perhaps to a larger corpus lutcum and are 
most probably attributable to the dose of gonadotrophin 
used to induce ovulation.
It is impossible, therefore, to consider 
gonadotrophin induced ovulation as noxvnal and the 
high excretion of pregnanediol and oestrogens noted by 
many investigators attests to this* There is however 
no reason to suppose that the time relationships of 
corpus luteum growth and persistence are altered by the 
pre%fious injection of gonadotrophins. The increased 
excrétion of pregnanetriol in gonadotrophin stimulated 
cycles where the level is higher than that normally 
reported are similar to those seen in cases of 
hydatid!form mole where there is also excessive 
stimulation as described in Chaptex^ 5#
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CHAPTER 8 .
Summary and ConeXu9Ions#
1. Summary
Chapter I# ïntrodyctiou to the Thesis#
r j r
The introduction discusses the thoughts leading 
to the studies and shows the relationship of the 
different chapters to each other#
Chapter 2# Epidemiological studies on abortion and
subsequent reproductive performance#
1# Women who start childbearing with 1 or 2
consecutive abortions are compared v/ith those 
%vho start with 1 or 2 normal pregnancies in 
respect of age, height, husband’s social class, 
obstetric performance in subsequent continuing 
pregnancy and later reproductive performance#
2# Women starting childbearing life with 2 abortions 
are older, shorter and of lower socio-economic 
status than the other 3 groups* Their problem 
is not ’fertility* but the difficulty of ’holding 
o n ’ to the pregnancy#
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3* In the first oositieuing pregnancy these women 
have a higher incidence of threatened abortion 
and premature labour* The perinatal mortality 
is increased mainly due to ’’prematurity’* and 
’''foetal deformity” * There is also an increased 
rate of operative delivery, of forceps after 
I previous abortion and of Caesarean Section 
after 2 previous abortions*
4* In the group with 2 previous abortions there is 
an increased tendency to poor foetal growth and 
the women with poor foetal growth also have 
premature labour* Meticulous antenatal care is
indicated in these women *
5# Eight percent of women who abort in their first 
pregnancy aborted in all their subsequent 
pregnancies and lOjS of this group had no 
subsequent successful pregnancy*
6# The recurrent abortion risk increases with
coaaecutivc abortions from tB% after 1 previous 
abortion to BBfo after 3 previous abortions#
7# One third of abortions take place before 2 months
155*,,
gestation ami have occurred by 3 monthe*
8* The results suggest that in abortion studies the
typo of patient who should he studied is the 
’primary recurrent ahorter* with two or more 
previous consecutive abortions and no pregnancies 
which have progressed past 28 weeks*
0* Initial observations 1ft abortion studies should
be made, at the latest, by 8 weeks of gestation*
If a previous abortion has ended at an earlier 
stage than 0 weeks the initial observations must 
be made before this time#
Chapter 3* Hormone assays in normal early pregnancy,
in abortion and in hydatidAform mole*
1* The metabolic pathways from precursors to
pregnanediol and oestriol are discussed.
2* Urinary pregnanediol and oestriol assays are
made in 5 groups of women (l) Normal pregnancy#
(2) Ifomon with at least 2 previous abortions and 
no stîcceasful pregnancies and (3) Women who aborted 
in the pregnancy studied*
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3# Thoro la no significant difference in oestriol
and pregnanediol excretion between the women who 
aborted and those in which the pregnancy continued 
successfully until 16 weeks gestation# Thereafter, 
%Aen the foetal component of oestriol production 
takes effect low oestriol excrotion is significant# 
There is no difference in the pregnanediol/oestriol 
ratio between successful and unsuccessful cases#
4# Urinary oestriol and pregnanediol assays are
of no value in forecasting abortion until after
16 v/eeke of pregnancy#
5* These two assays are performed in 5 cases of 
hydatidiform mole where the trophoblast is 
abnormal and the foetus is absent# Urinary 
pregnanediol levels are higher than normal in 
2 oases and lower in 3# The level of oestriol 
was normal until. 16 weeks in t case and then 
flattened out# In the other 4 cases it was low*
6* In hydatidiform mole urinary pregnanediol and
oestriol levels may bo normal but are more likely 
to be low# There may be some change in steroid 
metabolism in this type of case#
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Chapter 4, Conversion of progesterone to pregnanediol.
1. Pregnanediol is the characteristic urinary 
metabolite of progesterone but other more polar 
mat abolîtes are also excreted in the urine
. especially 6 and 16 hydroxylated compounds*
2. After I.V# injection of lOOpc. tritinted
progesterone the percentage radioactivity excreted 
as pregnanediol v/as measured in 4 groups of women 
(Î) Non-pregnant (2) early pregnancy (3) late 
pregnancy <4) abnormal pregnancy*
3. fhere was no significant difference between the 
ûûsi^prognant, earljf pregnancy and late pregnancy 
subjects, but there was a significant difference 
between abnormal pregnancy ami the other 3 groups* 
In particular the conversion in cases of 
hydatid if orm mole v/as low#
4# There was no difference in conversion in the 
same subject - pregnant and non-pregnant.
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Chapter 5# Progesteroïxe metabolism la the human
proviable foetus.
1# The levels of progesterone In the umbilical
VOS sels indicate that the human foetus raetabolises 
this hormone.
2* Perfusion of pro viable foetuses with 4-0^'^
progesterone for 14 and 45 raiautes followed hy 
extraction of the tissues and identification of 
metabolites shows that 40?S of the radioactivity is 
present in the liver after 14 minutes mainly as 
20a dihydroprogesterono. The adrenals at 
14 rainutes contain 3.4?^ of the radioactivity 
mainly in the form of polar compounds. After 
45 minutes the main compound in the liver was 
pregnanediol and in the adrenals polar compounds - 
probably co rtico st oroi d s.
3* The foetal liver ia the chief site of metabolism 
of progesterone and this organ produces mainly 
reduced metabolites. The adrenal also metabolises 
progostorono to polar compounds, sueh as 
corticosteroids.
ISQ#
4. Progestorona from the placenta is used by the 
foetus to produce cortieostoroids for its ovm 
homeostasis#
Chapter 6* Steroid studies in a case of hydatidiform
mole# .
I« fho increase in urinary pregnanetriol excretion 
in cases of hydatidiform mole suggests nn 
alternative metabolic pathway in these cases.
The prognanediolî pregiianetriol ratio in molar 
pregnancy is as 1 compared with that of 20s î in 
normaI pregn an ay.
2* Mole tissue was incubated v/ith [4-*^o3 pregnenolone 
ae precursor, and 17a. hydroxypregnonolone, 
progesterone# 10a hydroxyprogesterone and 
I6p hydroxyprogesterona were isolated.
3• Cholesterol# pregnenolone# Î7a hydroxypregnenolone# 
pregnanediol# pregaanetriol and androatenedione
■ -V > .
were isolated from extracts of mole tissue and 
theca lutein cyst fluid. t?a Hydroxyprogesterone 
was isolated from cyst fluid but not from mole 
tissue.
1 W .
4* Mole tissue is capable of atoroidogenesis but 
there was less eynthesis of progesterone than 
normal*
5. The increase in 17a, hydroxylation indicated hy 
the elevation Of the urinary excretion of 
pregnanetriol, is ovarian in origin# perhaps due 
to stimulation hy the large amounts of H*C«0*
circulating in these eases#
Chapter 7# Urinary steroid excretion after
gonadotrophin therapy#
Io ovarian steroid hiogenesis is controlled hy
and I.#11# It ia not clear that F#S*II* 
has any specific effect on steroidogenesis hut 
L#H# can increase the rate of conversion of 
cholesterol into progesterone and the do-novo 
production of the latter#
2» The major precursor, of prognanotriol is 17a-
hydroxyprogestcrone and there is a significant 
increase in the excretion of this metabolite in 
the luteal phase of the menstrual cycle# This 
is due to ovarian production of Î7a hydroxy-
16t.
progesterone#
5. Urinary pregnane trio 3. excretion also rises in the 
luteal phase of gonadotrophin stimulated oyoles 
and this may he a valuable measure of corpus 
luteum'function#
4# The excretion of this substance also rises In
early pregnancy during the grov/th of the corpus
i y"
luteum of pregnancy and folle to normal pregnancy 
levels after 6 - 0  v/eehs of gestation when the 
main function of the corpus lutcum of pregnancy 
appears to he past.
$. The pattern of urinary pregnane.trlol levels In
very early pregnancy agrees with that of the plasma 
levels of precursor 17a hydroxyprogesterone.
6. Urinary pregnanetrlol excretion up to 0 - 8 weeks 
of pregnancy may he valuahle in detecting the 
hyperstlmulatIon syndrome after gonadotrophin 
therapy# and also In monitoring the corpus luteum 
of pregnancy# It may indicate v/hen the latter 
is deficient wit# the resultant possibility of 
earl^r abortion.
3 02.
2. 0onelusi,ono
tm Women who begin childbearing with one or two
abortions have a relatively poor subséquent
reproductive performance.
2. Urinary oestrioi and pregnanedioi assays do not 
' help in forecasting abortion up to Hi v/eeks of
gestation and may not be helpful in diagnosing 
hydatldiform mole.
3. The conversion of progesterone to prognanediol
is low in abnormal pregnancy.
4. The foetus uses progesterone to manufacture 
adrenal atoroids for its own homooatasis.
5* The increased I "/-hydroxylation which takes place
in hydatid!form mole occurs in the ovaries probably 
due to stimulation by E.Q*G.
d., Urin'hry pregnanetriol excretion is a measure
of corpus luteum function in the menstrual cycle 
and of the corpus luteum Of early pregnancy.
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Fur the r work arising from this thesio#
U  Investigation into the control of steroid 
metabo-liom Isi the human 3'oetue and footo-
plac ont ai uni t #
2# Measeromcnt of other steroid motabolîtes e.g.
ê and 16 hyclroxylated mctabalitos of progesterone 
in the urine in pregnancy# normal and abnormal.
Ù «
4.
Further investigation into the use of pregnanetrioX 
and also of plasma 3?a liydroxyprogesteronc in 
early pregnancy to assosa corpus luteum function 
and its possible use in forecasting abortion.
The use of these assays in the prevention of 
ovarian hyperstimulation with subsequent multiple 
ovulation and multiple pregnancy in tlierapy witti 
human gonadotrophins.
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EXCRETION IN THIRD GONADOTROPHIN STIMULATED 
CYCLE IN CASE No. 3.
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ug^24hr
HCG
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URINARY EXCRETION OF OESTRIOL, PREGNANEDIOL AND 
PRSGNANEÏRÏOL IN AN OOPHORECTOMISED, HYSTERECTOMISED 
WOMAN AFTER STIMULATION WITH F.S.ÎI. AND H.C.G.
CASE No. 4,
HCG
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3224 2820128 160 4
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PLASMA 17a HYDROXYPROGKSTERONE LEVELS DURING 
GONADOmOPHIN INDUCED PREGNANCY.
(from Yoshtei et a I 1969),
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•FABLE 1.
i n c i d e n c e  o f  a b o r t i o n .
AUTHOR
TIETZE, aUT'i'MACISER AND RUB IN
HUDSON AND RUCKER
REPORT OF BIOL. & MED. COMMIS.
DAVIS
BAIRD
STALLViORTHV
HERTJG AMD LIVINGSTONE
STEVENSON, DUDGEON AND MCCLURE
INTER!)EPARTMENTAL COMM. ON 
ABORTION
TIETZE AND MARTIN
ÎÏHÏTEHOUSE 
MALPAS
Date
19S0
Î94S
Î9S0
Î950
1967
19SS
1944
19S9
1939
1987
1929
8938
Incidence
7.0#
10.0#
80.0#
10.0#
10.0#
10.0#
10.6#
11.8#
18 - 20# 
17.0# 
17.2# 
18.0#
TABLE 2,
COMPARISON OF 4 GROUPS BY AGE. (#)
m  IS* 19 20-24 28-29 304'
2nd Preg.
1 Abortion 6.5 38.8 34,9 20.8 100,0
3rd Ppeg.
2 Abortions 3.1 34,6 32.8 30.2 100.4
1st Preg, 11.9 51.8 20.3 10.0 100,0
Normal
2nd Preg.
No Abortions 2.4 34*7 3 7.8 26.1 100,0
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TABLE 4.
COMPARISON OP 4 GROUPS BY HEIGHT (#>.
Under
H E I G H T ________5* I"______ 5* 5,411 +
2nd Prog.
1 Abortion 20.7 61.7 27.0 100.0
3rd Prog.
2 Abortions 33.3 47.S 19.2 100,0
1st Preg. 23*0 49.0 27.4 100.0
2nd Preg.
No Abortions 24.0 30.0 26.0 100.0
'■ At
COMPARISON OP 4 GROUPS BY HUSBANDS SOCIAL CLASS (#).
SOCIAL CLASS 1 & % 3 4 6 5
(,l Preg.
1 Abortion 12.4 64.1 23.5 100.0
3rd Prog.
2 Abortions 14.7 56.0 30.3 100.0
1 Prog. 11.1 64.9 24.0
2nd Preg.
No Abortions 9.6 62.5 27.8 99.9
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TABLE 18,
TOTAL NUMBER OF ABORTIONS IN TlïO GROUPS.
Previous Aioortioû Group
'â’otal of Ho# of 
AMrti-ons
list#
-Normal Pregaancy Group
,iâ3„ESJBâ«ÈsL.
no. of
.WW<«rW«HI6WWe
  Paticut » % Patients Jk
I
s
B
a
7
2 0
8
6
2
0
Î9.S
7*7
6*6
Î . 8
10 12*1
6.0
1*2
1.2
0*9
Ï A 8 L E  17.
OTIMBKRS WHO ABORÏKO IN SUBSEQUENT 1PRE0NANG.IES 
gQLiOWÏNG 1st. ABORTION (TOTAL 83)
No. of women who aborted In 2nd Pregnancy -* 26 (2,$%)
No. of women who aborted in 3rd Pregnancy
after 2 previous abortions *• 12
$ of those who aborted in 2nd Pregnancy * 46j^
No. of women who aborted in 4th Pregnancy
after 3 previous abortions - 7 (6.7%)
% of those who aborted in 3rd Pregnancy - 38*3%
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TABLE 19
GESTATION PERIOD AT WHICH ABORTION OCCURS
1st. Pregnancy ending in abortion
Time of Abortion»j!*iv.wt'in'c«j«*wpe<#t>irw«» MWM IM unm»W I***»#*»*-  ^^ Number ^ ^
Up to 2 months 283 32.8
2 months « 3 months 13} 18.1
3 months •• 4 months 29 6 34. 1
Over 4 months 137 18.1
TOTAL 869 100.1
TABLE 20.
GESTATION PERIOD AT WHICH ABORTION OCCURS
2nd# Pregnancy ending In abortion
Time of Abortion Number %
feiHlCi‘Ha.aaV?gsiH?^a*'?a:»;a‘iW«faaTCa«j:0c=j»»zaa»Mn’*-^aMiia\tEratjjjiaggyaacira>i!ng!^,*KiJriigjW'»g"5iiwwii^ae--agJ!B0p.v^
Up to 2 months 37 80#3
2 months - 8 mouths 24 19# 7
8 months ## 4 Eiontha 39 32 #0
Over 4 months 22 !8#0
TOTAL 122 100#0
TAOLfâ 21.
GESTATION PERIOD AT WHICH ABORTION OCCURS
Third Pregnancy ending in abortion
Time of Abortion Number %
Up to 2 months B 33*3
2 months ** 3 months % 8.3
3 months 4 months 9 37*5
Over 4 months 5 20*8
TOTAL 24 09.-9
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TABLE 23.
INTERVAL BETWEEN 1st. & 2nd. PREGNANCY 
(to noapost year)
Interval
in Years No* %6y:î»«rj<Wv«i>»*vtrtwwriii.amF!iflwci!»et»«.(ieKtKE»aeJ-iti-eiïsta™iTr»Wif"si5!SaiKM<«wir«ïe:
1st* Abortion 
No. .. %; n #Mt 3» fjT'KAMTAK?# ' Hi fH V
1 14 17*1 64 50.1
17 21*0 38 50.0
3 16 20*0 9 7,0
4 8 10*0 2 1.0
5 4 5.0 5 3,9
i 4 5.0 0
7 3 3*7 1 0,8
a 4 5*0 0
0 1 1*2 0
Î0 0 0
Nil Î0 12*4 8 6.3
TOTAL 81 100.4 12? 99.7
TAB L E M ,
INTERVAL BETWEEN 2nd, & 3rd, PREGNANCY
# #*#ww
1st* Prog# Normal 1st* Preg# Abortion
Interval
28.0 
22.0
9.5 
Id'.O
3.5
4.6
in Years No# %. .No,fpA# îOl *fWM
Î 17 24#0 24
2 0 a#6 W
n 11 15.8 8
4 a 11.4 12
S Ï 1 #4 3
6 2 2.85 4
7 0 M» 0
8 Î 1 .4 0
B 0 •t* 0
10 0 e
Nil 24 34.5 16
TOTAL 70 90.95% 8 6
18.6
100,0^
i H i E o n m m i o h  ekore?ion • normal piieonancy 
(from Klopper & Blllmviez (I0G5))#
w.eeRs of Excretion in mg/24lir. (£ so)®
(Number of cases in bracketeO
B — - -
0 3*18 <2)
7 3*18 (2)
8 7*3? 1.169 (S)
8 7.91 t’ 2.544 (6)
10 8.48 4’" 1.826 (7)
II 10.06 2*761 (7)
12 10.58
4.
2.289 (8)
IS 11.04 t 8.008 (8)
14 11.77 ■V 3,019 (S)
15 12.91 8,660 (6)
la 12.38
4s
6* 168 (6)
EiaMANEDÎOL EXCRETIOW <- SO) IN PATIENTS 
'iîXTH 2 OR. r.îORE PREVIOUS AS0RTÏ0NE1, 
PRESENT PaSGRANCy SUCGBSS*'””
(HUMBEa OF CASES Sfl miA
la A
WookÉ» of
É^r»i
•Ü
7
12
Î4
PregnanocLiol oxerofcloo
If *-!»Fïse*5WWS>:
e»e* vs
e.o
B #4 
8,8
*S i
10,2
11.7
12,0
14,1
C 3) 
2.9S < 4) 
U 0 O  ( e) 
2.3S ( 8) 
2,49 (11)
2.!
3,26 
S. OS 
4*2? 
5.^
( BO
PATESNT8 Wî!Ô ASORTRO ÏW PaKSBKT PftRS.WANCV, 
(NUMBER OF CASKS IN üflAGKCTS).,
W«oks of excretion
15
10
5.
s 6*5
0 0.8 4® 2,47
7 S,7 4® f.ss
0 0.8 s.47
0 , 7,9 i-" 3,08
to 8.0 s . t a
It 7*7 3*89
18 7,9 i* 8.73
7,8 k. ÎÎ.0S
%4 m *8 t 1*69
«0.C
»*'
i 3)
■'♦o
' R m e  28*
iESTRÏÔl. SKeSF'P' (t 8») ,
HO&MAL SSCKE'i’IOK, 
NlBlsiKR OF CASES IN BllACKETS)
lïôeîîB -of
5 0*040 t 0,046 (4)
5 0*041 ’f»
y 0*101 ■'I'- 0,04sa (?)
0 0*110 •Î®- 0,0.546 (8)
0 0*204 0,063 (0)
# 0,2.23 (7)
$1 0*52 ■;^ 0,64 (&)
0.40 ic 0.307 (s)
98 0.06 t 0,3 79 (0)
1.0? j; 0,734 (73
15 1*76 0.090 (0)
10 %.ee 0,749
o ABORT]
oES'mïoî. EseftBTSow $ s»).
If f ‘s" tüîia 4A
FüBSEKT PEKONAN0’/ S 
CNURtSfîE or PAflKRITS ÏN PRACKBT8)
U *
$
ê
f
ê
n
14
B a
0.216
0.400
0.790
2.06 :
r 0*018
4. 0*040
i- 0,03 î
t 0.126
0.134
i" 0,107
i" 0,304
i 0,200
t 0,002
J..
0,340
Vf* 0.S99
4' 0,620
TABLE 30,
OKS'fftîOi, BXCaSTlON (t 30),
PATÏ.8WT3 WHO ABOETEB Î.R PRSSBN'ff FkKGMARCY.
CKüMsrîîi OF Ph'mmt'Q m  bracicbts), 
tïoùkfi ai Oestrioî amip&uiati
m s î B z ___M*f/24hï"«
& ©,0?8 (2)
0 0,065 (3)
? 0,040 t 0,0024 (4)
Ô 0,052 t 0,0414 (4)
B 0,803 t 0,0681 (4)
10 0,803 es)
t1 0 .1 3 ■t 0, Î90 (4)
12 0,30 (2)
m 0,3 (2)
14 Ô.ÔÏÏ (3)
16 0,09 (&)
10 1,755 (2)
TAB LU
RATIO OF BXCaUTION OF FRRGNAMBDIOL & OESTRIOL
N O a m L  RATIO#
(NUMBEtlOF CASES IN BRACKETS)..
Weeks of
Ratio
0 181*7 f 93.8 (4)
a 147*9 64.2 (5)
7 92*0 32. Î (7)
a 0S#4 ■4e 20,6 (8)
# 01*1 33,4 (8)
Î© 40*0 i* 1?,2 (7)
It S6.4 "4* 29,2 (6)
12 S7*8 t 33 ,S (8)
IS S4*0 i-» 4Î.1 (6)
14 22*0 24,1 (7)
IS 7.5 4" 6,71 (6)
10 5*2 4’ 3,16 (s)
TABLE 32^
R A T IO  O F R S G R S T IO K  O F PREONAMEI) ÏO L  â  O K S T R ÏO Î,. ( t  SB 
P A T ÏB N ’f S  W IT H  3  OR MOHiî P R E V IO U S ' A B O R T IO N S .  
P l A B B l î m '  P R E O R A H C t S O C C E S S F O L . 
iSP, OF CASSS I N  B R A C K E T S ).
Weeks of 
lirjiHliBS; Ratio
0 139,8 67*0
6 48.8
? 79,40 48,6
0 40,57 1* 26.9
9 00,26 40,83
4S*S t 34,4
II BS,0S 34,0
S U S S t 20,0
18 88.28 10,4
84 14,4 "|w 7,40
15 80.85 s,s
Î© 7.6 i' e.®
S
B)
a)
8)
m S L E  S3,
HAfli) OF SXC&KTIOK OF. FaEGNANAîBÏOL ê OESTftSOi #  SB)
PATIEKfO WHO ABORTEO SK W4ËSSIOT FREGflAKCY
ill OF, CASK8 IN BRACKeTS);',
s . 74,0
Q os*c ’t 80,4 iT,)
f 113,3 t SI,7 (4)
& 112,0 4- 34,6 (4)
9 74. S so.o
72*7 SQ*& C3)
ÎÎ 93 ,4 i' 67,8
«2 29,3 c ^
31,0 C2)
14 16,8 0,7 (3)
16 18,6 (2)
16 ##
TA8L6 $4.
EXCRETION OF OESTROGEN AMD PREGMAMEDIOL IN  HYDATIDIFORA] MOLE
Weeks oÉ' R a t io  o f  O e a t r io l i
Case Pregnancy o ea tro n e  O e a tra d io l O e a t r io l  O estrone & O estradioJ
No. from L .M .P #  M g/24hrk n g /2 4 h r , P 8 /2 4 h r*
MwmmfKtawwwKKui
10
11
12
13
14  
16  
1Z
4 0
1 6 . 3
2 9 0
308
3 8 8
2 6 4
5 0 4
2 6 . 5  
7 3 . 0  
12 5  
10 7 
1 7 6  
100 
108
*Ag/24hr.
P re g n a n e d io i
m8/24hr#
Ç-i^iv'39's»3aFC7a#gi£5itc:ra>; «WS Wîï
1 5 6
385
5 6 5
6 3 5
7 4 2
8 2 8
8 4 0
2 . 3  
1 . 6
1 . 3  
1 . 5
1 . 4  
2.2 
1 . 3
5 . 9 2
1 0 . 5  
22.0
2 7 . 0
3 1 . 0  
2 1 .0
51.5
11
12
14
17
19
2 5
5 . 5
4 . 0
2 7 . 0
1 1 . 7
1 7 . 5
9 . 0
2 . 5
9 . 5  
2 . 7
122
4 4
31
4 4 . 5
1 4 . 8
2.8
3 . 0  
4 . 7  
1.2
1 .0
6 . 5  
6.0 
2 . 4 3
2 . 5  
0.8
15
16
17
18 
19 18 3 2
2 3
21
2 3
17
2 4 . 5
16
17
18
19
20
14 6
10 4
173
4 . 6
7 . 5
7k5
8 . 3
9 . 0
11
12
13
14
15
16
1 3 4
5 6
14 4
15 4
16 0
8 4
4 . 0
3 . 0
4 . 0
5 . 5
6.6 
6 . 5
EXCRETION OF
( fro m  F p and s en & S t  a keman ,  19 64)
Weeks of 0R% OEg OEg
Case Amenorrhooa M $ /2 4 h r , p g /2 4 h r . p g /2 4 h r ,
OEo/ Q P
OEfi OEa IU /2 4 h r .  m g /24hr
K .K . 19 * « 85 *
20 - 2 10 -
I . N . 25 21 12 104 3 .1 132#000 3 .2
26 26 12 138 3 .1 6 5 0 ,0 0 0 3 .2
A .O . 16 - - 260 700,^000
Il *A • 16
17
106 4 6 219
280
1 .9 6 0 0 ,0 0 0 3 .6
G .8 . 16 - ' - 525 -
18 - - 1100 -
K .8 . 18 - - 1100 2 4 ,0 0 0
L .M . 20 43
■r - ■■sv'A î i S i '
' S Ê Ê M m M - i S i t l ; .
L . 8 . 12 117 29 126 0 .9 8 5 4 ,0 0 0 7 .6
13 - - 132 2 4 7 0 ,0 0 0
14 77 66 130 1 .0 2 6 0 0 ,0 0 0 7 .7
15 2 62 187 240 0 .6 2 6 4 0 ,0 0 0 5 .6
18 - - 194 6 7 0 0 ,0 0 0
17 - - 425 8 4 0 0 ,0 0 0
B .n . 11 - - 184 -
15 62 19 102 1 .3 2 4 0 ,0 0 0 1 .9
I . E . 32 (? ) 94 68 335 2 .2 4 6 ,0 0 0 3 .4
OEj_ -  o e s t r ô n e  
0K<5 »  O e s t r a t l i o l  
OE-} *  O o s t r io l  
G » G o n ad o tro p h in
P » P r e g r i a n o d i o l
TABLS 36.
BAILY AND S BAY TOTAL PERCENTAGS REGOVSRV OF
i^.,.jjiiSüsia^ciimA2î»_iiâSM
0aAî.y % Recovery
4
&&%Ê î g 5 4 S Tota.1 1
RGCOVOi
1 S»60 1 »4S 0.48 O.s!» 0,0? 6, G»
Ê Ô,SÏ l é4S @*y? 0.08 O.îîf IUS4
S 8.4? 0.OS s. 4? UÏ9 o.os Î4.2Î
■^ 0,a? 0.00 0,04 0.3S 0.1Î a.Sî
s 2.02 2.0? 0.64 0,28 0,25 6,06
TABLE S?*
DAILY AN» S DAY TOTAL PERCENTAGE RECOVERY OF X.V, 
INJECTED TRÏTJATED PROGESTERONE AS URINARY FREQ- 
KANEDÏOL m  ELEVEN SUBJECTS 7 - 1 9  WEEKS PREGNANT
■^WlSîSrtjiïWiïi vt #Ki!##i:#PwArn  ^ eigia*iiRtCti<*i:i*î4iÉiMt*>eiL’ütoWi6‘Xî5p<t#<s,Wj-u.W*ie*ï*w.59»iîï><t
Week of Bally fo Recovery Total %
ase Gestation % 2«Wstme wwi*. W1» svjMES^-a*3s-»«(trHw»'»»«9KiT«ris,-WcwiiM.;,T» ^ _ ___. ^^RecQVcry
0 7 6*03 i # m 0.77 0*79 0*46 8*64
7 8 10*60 S.32 1.18 0. 14 0.43 15.67
a 10 2.3 1 1*60 o.so 0.29 0*26 4*66
9 12 7. 10 1.70 1.10 0.50 0.15 10*55
m IS Î U S O 2*10 1.30 0.66 0.09 15*14
n 16 ■8.80 0.73 0.76 0.46 10.79
12 16 3.84 0*70 0*38 0. 16 0. 14 5*22
IS 18 16*70 2.60 0.66 o.so 0*13 19*59
14 16 6*67 0.38 0*33 0. 19 0.24 6.81
16 18 8*28 2.00 0.62 0.24 0. 14 11*28
10 19 6.95 0.88 0. IS 0*34 0. Î4 7.44
TABLE 38.
fl.*s3y*iH™wi»c*s3raer*s'»i
DAILY AND S DAY TOTAL PERCENTAGE RECOVERY OF Ï.V.'   '  ' '     .
INJECTED TRÏTIATEO PROGESTERONE AS URINARY PREG- 
MAW D I O L  IN SUBJECTS S9 and 40 WEEKS PREGNANT
Week of Pally % keoovery total %
Case Gestation 1- 2 3 4 5 Recover:
0.11 5.80
0.07 18.36
0.07 8.08
17 39 4.G8 0.34 0.45 0.22
Î8 40 13.00 2.24 0.28 0. 10
19 40 6.23 1.07 0.53 0.18
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TABLE 40,
c o m p a r i s o n  o f  TIU-: a v e r a g e  t o t a l  î'ERCSiNTAOfi RECO VERED
P R B tlH A N R O IÜ L  Ï N  T iU î. F IR S T  H IV E  OAYS PO ST IN J E C T IO NKV-*-,®-.j" % « . % * : ! Æ<»lrtï.ï.r,7®'.;v;tils,K^ltJJKJiïtiCAfcrt/Ja.-Wît'st‘##«siî3sf rtîïli- Jlrttv:,ML'a,*1rtSÏ«!Xnj W
M  F o m  GROUPS OF WOMEN
Wo# of Average % standard
C m o B  Recovered Baviatii
U q u ^ prcgriau t n 9. 10 Î 3.62
week g coûtât ion 10,53 t 4,09
30 ê 40 woelG gestafcian 10,38 Î 0,41
Abnormal pregnancy 9 6,32 tz,B&
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TABLiS 42.
 PRÎiOKANgDÏOL gXCREÏÏOK l»mCBNTAQB CONVgRSlON
OF TRiTXATSIJ FP.OO£STBkOP3g TO URINARY FiiSOWANBOIOJ, 
AND SPSCIFifl ACTIVITY OF fllB PR80NANB0Ï01. IS A
WOMAN WITH NO UTERUS
Day P M g a a n W l o l
Oonveralon
to
:gpoGlfjle Activity olT 
Dr%:%oneUio3, d l ooataW
Î 1.S8 a,10 360.2
2 1,48 0.08 363.0
a 1,24 0*62 S97.4
4 1.70 0.3S 116.8
s 1.27 O.ÎS as.8
1TG#;6&& 33» Gk&#rv<eHri&@(& «» ip*c;<&g;
TABLE 43.
m m s â u m m m
Patient 1» Oasct S. WoiJ-PiHigaaîife Case 2! Fî'0gna«t
%
HÜîSXSEiâ Ê&&& i ê s s m s â SaiÔsÆ.
1 2 #92 610.8 3,02 329.0
i 2.07 SÎ3.0 1,20 162.4
S 0.64' 139.9 0,64 73.6
4 0.26 64.8 0.08 16,0
0,38 87.4 0,26 26,6
Totai ' §#0# 4,28
Patient 0* Oaae 4*
' ^
Ror»™>Ppsgaaat Ü0PO 8
&iSËXS£iâ
Pî'Ogaasit
&&&*
1 0,67 20ÎS.S 2.31 468.3
0,96 422.9 1,60 I4S.4
& 0.S4 Î9S.0 o.ss 82 .2
4 o.ss J 1S.Î 0.29 02.4
S 0,1! 3Î.Î 0.20 Î6.6
Total 8.61 4.6Ô
(s,A, » SpaeAfie ActAvAty)
TABLE 44,
UîlîflAîl? PRKGNANKBÎOL EXCRETION, PERCENTAGE CONVERSION 
OP TRÏTÏATE» PROGESTERONE TO URINARY PREGNANEDïOL,1.1 Uif ME-’«fîi3^j(^nv wt> qnwa,^ #w*i .w»i u# *** iMMtrRi «#r#ü#g w# */#«%[ &i w.r 7.71 fcy^-jc y?sfn:s sesR wamw
AND SPECIFIC ACTIVITY OF THE PRBGNANBPlOI, DIACETATE 
PRSONANE0ÏO1. EXCRETION AND DELIVERY OP LIVE CHILD
Specific Activity 
of pre^nanediol 
Prog'nanediol % Converted to diacetate
Day
4i'iJ fww,wr=3) c
mg # P rog n a no ci i 0 1 ( mp c/mi
Ï 3$%6 0*$9 05. 1
z 2.S 0.06 10.1
0 &.0 0.02 7.D
4s 2*8$ 0*01 2.8
B 2*t$ 0.005 1.0
Total % converted - 0*40^6
p ï s t r ï b u t: rs COMPOUNDS ÏN TUS *FREE
14 m m #  AFTEE INJECTION
m o Q m m m m . INTO A HUMAN FC»BTUS
% of Total Radioactivity
MetaDo.iitc .esent in
tivër ' " U S i l i
Fûlar Material 16,6 47.0
Pregnanediol 19.2 13.3
aûa«*ditiydr0progeaterone 36,5 17,8
20p«-diliydroprûgesterone 1t.0 6,7
I Pragnaaolene 3.2 0
Progestérone 13.4 15,6
DISTRIBUTION OF RADIOACTIVE COMPOUNDS IN THE 'CONJUGATKO'
FRACTIONS OF LIVER AND
A HUMAN FOETUS—^8 I, IMM
# of Total Radioactivity present 
in the tw<
W a g e
1 2
Adrenals 
Î "T
Polar Material 20,S 29.8 45.8 100
Pregnanediol 31.9 54.6 S0.9
20aë»dlihydroprogest6roiia 19.4 0.0
2Op*^dlhy<ir0prog0sterone 9.9 0.0
Frogrianolone 7.5 0 #4" 0.0
Progesterone 11.1 0*2 14.5 -
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